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The thesis comprises the study of counterfeit drugs in the Middle East and 
Subcontinent. An extensive literature review was carried out about counterfeit drugs 
across the world, consequences of counterfeit drugs and study about various 
strategies combating counterfeiting. 
 
The thesis concerns the research project aiming the analysis of amoxicillin in 
counterfeit antibiotics. Various techniques used for the analysis of amoxicillin such 
as High Performance Liquid Chromatography, Capillary Electrophoresis and Infrared 
Spectroscopy were also studied in detail for developing ideas and to approach 
scientifically towards the research on counterfeit drugs. 
 
A suitable method was developed for the CE analysis of amoxicillin in order to 
achieve better analysis i.e. accurate and repeatable. Amoxicillin was analysed using 
HPLC and CE and then the results were further confirmed using FT-IR technique. 
 
The results obtained using HPLC and CE are comparable and suggest that almost 
all the different brands of amoxicillin (excluding sample 10) contained the active 
ingredients more or less the amount stated by the manufacturers  and did not show 
counterfeiting. Different brands of amoxicillin were found to contain active ingredients 
within the internationally acceptable limits i.e. a sample tablet or capsule of 500 mg 
should not contain less than 90 % of active ingredients of the stated amount and 
similarly no sample should contain more than 120 % of the stated amount (United 
States’s Pharmacopoeia). Although all the samples show repeatability within the 
same sample capsule, still a variation in content uniformity is observed between 
different sample capsules within the same brand of amoxicillin. 
 
The comparison of results obtained from the analysis of all different brands of 
amoxicillin show the difference of quantity of amoxicillin found in the sample 
capsules of the same weight between the different brands but it also show the 
difference between results obtained for different capsules of the same brand 
(variation of content uniformity within a particular brand). 
 
Sample 10 was highly suspected to be a counterfeit sample as one of the sample 
capsules (sample capsule 10a) did not contain any amoxicillin at all. These results 
were confirmed when sample capsule 10a was repeatedly analysed using HPLC and 
CE. The results produced by sample capsule 10a after each analysis on HPLC and 
CE were the same such that no peak was found for sample 10a after several 
repeated analysis using HPLC and CE techniques. 
 
Further analysis of a 4th capsule (capsule 10d) from sample confirmed that it 
contained almost the same amount of amoxicillin as stated by the manufacturer. 
Hence, this analysis suggested that the manufacturer of sample 10 might have 
produced the antibiotic meeting the international standards of quality control and the 
























Glossary of Terms:  
 
CE: Capillary Electrophoresis 
HPLC: High Performance Liquid Chromatography 
FT – IR: Fourier Transform Infrared  
ATR-IR: Attenuated total reflectance Infrared 
DRIFTS: DRIFTS Diffuse Reflectance Infrared Fourier Transform Spectroscopy 
TLC: Thin Layer Chromatography 
MeOH: Methanol   
RFI: Radio Frequency Identification 
RFID: Radio Frequency Identification Data 
DNA: Deoxyribonucleic Acid 
RNA: Ribonucleic Acid 
SDS: Sodium Dodecyl Sulphate  
UV: Ultra Violet  
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Chapter 1:   “Introduction”  
This chapter comprises the aims of project, introduction and explanation of 
counterfeiting, antibiotics, properties and classifications of antibiotics and their 
various applications. The chapter also includes the theory of the analytical 
techniques which were used for the analysis of the antibiotic Amoxicillin in this 
work. 
 
1.1. Aim and objectives: 
Counterfeiting or the production of fake drugs is nowadays one of the most 
serious and threatening issues around the world, particularly in the developing 
and poor countries. The problem of counterfeiting is most prominent in Asian 
countries and can be found in a few developed countries as well. Before starting 
this research project, an extensive literature review was carried out and the life 
threatening problem of counterfeiting was studied in details.  
 
The aim of the project was the analysis of amoxicillin in counterfeit antibiotics 
from the Middle East and Subcontinent and the project had the following 
objectives. 
 
1. The collection of antibiotics from different companies of the Middle East 
and Subcontinent and analyse them quantitatively and qualitatively.  
 
2. To establish new methods of analysis for antibiotic amoxicillin if possible 
by using HPLC and CE technique. 
 
The initial HPLC and capillary electrophoresis analysis was performed through 
the quantitative analysis of some common pain killers such as aspirin, caffeine 
and paracetamol. The aim of analysing these compounds was to gain practical 
knowledge for the use of these modern analytical tools used in this research.  
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Once the analysis of aspirin, caffeine and paracetamol was successfully carried 
out, the analysis of different brands of amoxicillin was then carried out for the 
purpose of finding counterfeiting if any. 
1.2. Counterfeit drugs:  
 A counterfeit drug or medicine is defined as a medication which is deliberately 
and fraudulently mislabeled with respect to identity, composition and source 
(Newton. P.N, et al: 2006 Lancet, 6. 602-610). 
 
They are produced and sold in the market with the intent to deceptively represent 
the origin, authenticity or effectiveness of the original drug. The definition of 
counterfeit or fake drugs includes not only completely fake drugs but also those 
drugs that have been diluted, tampered with, adulterated, repackaged or 
relabeled so as to misrepresent the dosage, expiration dates and origin. These 
drugs are also known as substandard drugs and are cheaply produced in order 
to make unlawful profit. These medicines are sold in the market by labeling them 
as of the same standard as set by the local drugs regulatory authorities. 
 
The counterfeit drugs are likely to contain insufficient quantity of active 
ingredients, or may contain entirely incorrect active ingredients (contaminants) 
(which may or may not be harmful), and which are typically sold with fake 
labeling and fake packaging. 
 
Counterfeit drugs can generally be classified by the following characteristics: 
 Re-labeled drugs that were previously expired, defective or otherwise 
deemed unfit for use. 
 Re-labeled drugs wherein the active ingredient is fraudulently diluted. 
 Re-labeled drugs wherein the active ingredient is adulterated or substituted. 
 Falsely-labeled substances whose combined active ingredients meet one or 
more of the preceding criteria. 
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1.2.1. Consequences of counterfeit drug application:  
 The extent of consequences caused by counterfeit drugs is unknown. However, 
individuals on counterfeit medication may experience a number of dangerous 
consequences to their health, such as allergic reactions, unexpected side effects, 
or a worsening of their medical condition. Some times the counterfeit drugs may 
be without any active ingredients, and may contain inert substances, which may 
not provide the patients any treatment benefits. 
 
The problem of counterfeiting is difficult to detect, investigate, and quantify.  It 
simply means that it is hard to know or even estimate the true extent of the 
problem. It is estimated that counterfeit drugs account for nearly 1 % to 50 % of 
the worldwide trade in pharmaceutical industry (Newton. P.N, et al: 2006 Lancet, 
6. 602-610). 
 
Counterfeit drugs are more likely to be introduced as a part of drug distribution 
process involving multiple wholesalers. In the current distribution system, 
products are repackaged for several legitimate reasons, such as to improve 
efficiencies for automated systems. However, in Europe, the products are 
packaged in quantities that relate to a course of treatment (unit of use,) thereby 
avoiding the need for repackaging. 
 
The problem of counterfeiting is most threatening in the developing world. It has 
been found that these substandard drugs are available in the markets across the 
developed world as well but the problem is more severe in developing world as 
compared to the developed countries like the UK and USA (Charatan: 2001 
British Medical Journal, 322-144). 
 
In the developing countries, the counterfeiting is found to be targeting the drugs 
which are used in high volumes and are used for the treatment of life threatening 
diseases. These drugs mainly include antibiotics, anti-malarial drugs, drugs used 
for the treatment of heart diseases, anti-viral drugs, anti-cancer drugs and the 
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drugs used for the treatment of HIV/AIDS and TB (Khan, et al: 2007 Indian J. 
Pharmacol, 39. 206 - 207). 
 
According to the estimation made by the US FDA across Asia is that the trade in 
fake drugs is from $35 billion to $45 billion, as many as half of the drugs are sold 
to be believed substandard are fake drugs. These include drugs for AIDS, 
tuberculosis, antibiotics and even meningitis vaccines and anti-malarial drugs as 
well (Khan, et al: 2007 Indian J. Pharmacol, 39. 206 - 207).  
 
According to the UK’s Daily Telegraph report (August 2005), as many as 100,000 
people die each year in China as a result of taking counterfeit or fake drugs. 
These figures indicate that the counterfeit drugs are found in high ratio in china 
as compared to other neighboring countries (World Pharmaceutical Frontiers: 
2008 The Cost of a Cure). 
 
In Pakistan, the problem of counterfeiting is threatening the public health on a 
large scale.  These drugs are sold in pharmacies and small shops in the market 
under fake labeling and packaging.  
 
These counterfeit drugs are always sold with names similar to the original 
products. The problem of counterfeiting is most prominent in small cities and 
towns where there is a lack of education and the people are mostly illiterate.  
 
The drug controlling authorities in Pakistan are taking strict and positive steps to 
defeat the problem of counterfeiting in Pakistan. The law enforcement agencies 
are also working together with drug monitoring agency to uproot this threat of 
counterfeiting. 
1.2.2. Combating counterfeiting in Asia with the help of new 
technologies and plans.  
There are several technologies that may prove helpful in combating the problem 
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of counterfeiting, such as radiofrequency identification, which uses electronic 
devices to track and identify pharmaceutical products, by assigning individual 
serial numbers to the containers holding each product. 
 
As stated earlier, counterfeit drugs are a threatening and dangerous problem in 
Asia. In most of the Asian countries, about half of the total drugs produced are 
counterfeit drugs. Poor public health conditions and high prices of drugs have 
provided a chance to the industries producing counterfeit drugs and selling them 
on cheap prices. As a result in some Asian countries, the governments and 
pharmaceutical industries have begun to struggle more combating the problem of 
counterfeiting. 
 
Some pharmaceutical companies including GlaxoSmithKline, Merck and Knoll 
pharmaceuticals have implemented special type of holograms on their products 
in order to differentiate them from counterfeit or substandard types.  
 
The Malaysian ministry of health has also introduced such holograms on their 
pharmaceutical products as a security measure. These holograms are tagged 
and registered with Meditag, a security device. Each Meditag has a unique serial 
number and can be scanned with a special device to verify its authenticity. 
However, these holograms are not too much dependable as it is possible to copy 
holograms. Hence they are not sufficient to stop counterfeiting (Pacific Bridge 
Medical: 2006 Asian Medical eNewsletter). 
 
Another technique is radio frequency identification or RFI which contain a chip 
with an antenna is affixed to the drug packaging. The exact location of the drug 
can then be found by radio waves. This technology is not cheap but is said to be 
one of the most effective techniques developed so far to uproot and stop 
counterfeiting. Some pharmaceutical companies such as Purdue Pharma and 
Pfizer have already started RFID technology to trace their respective products, 
OxyContin and Viagra (Pacific Bridge Medical: 2006 Asian Medical eNewsletter). 
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In order to combat counterfeiting, the pharmaceutical scientists are looking to 
produce drugs through reaction mechanisms comprising of several step 
reactions rather than simple and short reaction mechanisms. The reason for 
following long and complicated reaction mechanisms is to make the production of 
life saving drugs more expensive and complicated so that the counterfeiting 
industries are unable to produce the life saving drugs. 
1.3. Antibacterial Antibiotics: 
Historical Background 
The historical background of antibiotics can be summarised as follows 
 As early as 500 to 600 B.C., molded curd was used in medicines by 
Chinese to treat boils and carbuncles. 
 Chinese also used molded cheese to treat infected wounds which is 
assumed to possess antibiotic substance. 
 Sir Alexander Fleming discovered the antibacterial properties of penicillin 
in 1929 (Microbiology Procedures: 2007 Antibiotics).  
 
In 1877 Pasteur and Joubert discovered that anthrax bacilli were killed when 
grown in a culture in the presence of certain bacteria (Microbiology 
Procedures: 2007 Antibiotics). 
 
 Later on Florey and Chain introduced amoxicillin into therapy thus begun 
the practical medical use of antibiotics. 
 
Definition of antibiotics 
Antibiotics were defined in different ways by different people in early days. Some 
of the definitions are given as follows 
 
1. Vuillemin to define antibiotics (literally, against life”) as the biologic 
concept of survival of the fittest, in which one organism destroys another 
to preserve itself. 
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2. According to Waksman, “an antibiotic or antibiotic substance is produced 
by microorganisms, which has the capacity of inhabiting the growth or 
even of destroying other microorganisms” (Microbiology Procedures: 2007 
Antibiotics). 
 
Later proposals have sought both to expand and to restrict the definition to 
include any substance produced by a living organism that is capable of inhabiting 
the growth or survival of one or more species of microorganisms in low 
concentrations. 
 
Later on, naturally occurring antibiotics were modified into synthetic antibiotics. 
This advancement permits to define a substance as an antibiotic if it meets the 
following conditions. 
 
 It is a product of metabolism (although it may be duplicated or even have 
been anticipated by chemical synthesis). 
 It is a synthetic product produced as a structural analogue of a naturally 
occurring antibiotic. 
 It antagonises the growth or survival of one or more species of micro-
organisms. 
 It is effective in low concentration. 
 
Applications of antibiotics: 
The successful use of antibiotics in the treatment of human diseases has 
prompted the expansion of their use in a number of related fields. Extensive use 
of their antimicrobial power is made in veterinary medicine. 
 
The discovery that low-level antibiotic administration to meat-producing animals 
resulted in faster growth, lower mortality and better quality, has led to the use of 
these products as food supplements. Several antibiotics are used in the 
treatment of many bacterial and fungal diseases of plants.  
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Their use in food preservation is being studied carefully. Indeed such uses of 
antibiotics have made necessary careful studies of their long term effects on 
humans and their effects on various commercial processes (Gurdeep, R. 
Chatarwal, and Sham Anand: 2000. 5th). 
 
For example, foods containing low-level of antibiotics may cause allergic 
reactions in hypersensitive persons. Similarly the presence of antibiotics in milk 
may interfere with the formation of cheese. 
 
The success of antibiotics in therapy and in related fields has made them one of 
the most important products of the drug industry today.  
 
 Production of Antibiotics: 
The commercial production for medical use follows a general pattern, differing in 
details for each antibiotic. The general pattern may be divided in to six steps 
(Herbarium USU, 2007 Production of Antibiotics). 
 
1. Preparation of a pure culture of the desired organism for use in the 
inoculation of the fermentation medium. 
2. Fermentation during which antibiotic is formed. 
3. Isolation of the antibiotic from that culture medium. 
4. Purification. 
5. Assays for potency, sterility, absence of pyrogens, and other necessary 
data. 
6. formulation into an acceptable and stable dosage form 
 
Spectrum of activity: 
The ability of some antibiotics such as chloramphenicol and tetracyclines, to 
antagonise the growth of numerous pathogens has resulted in their being 
designated as, “broad spectrum” antibiotics. Designations of the spectrum of 
activities are of somewhat limited use to a physician unless they are based on 
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the clinical effectiveness of the antibiotic against specific micro-organisms. 
Many of the broad spectrum antibiotics are effective only in high concentrations 
against some of the species of micro-organisms often included in the spectrum. 
 
Reaction mechanism of antibiotics: 
The manner in which antibiotics act against microorganisms is varied. The 
mechanisms of reactions of some of the more common antibiotics are listed in 
the form of tables depending on the site of actions as shown in Tables 1, 1.1, 1.2 
and 1.3. 
 
Table.1: The reaction mechanism of antibiotics the site of action being cell wall. 
 
Site of 
Action Antibiotic Process Interrupted Type of Activity 
Cell Wall Bacitracins 
Mucopeptide 
synthesis Bactericidal 
  Cephalosporins Cell wall cross linkage Bactericidal 
  Penicillin e.g. Cell wall cross linkage Bactericidal 
  Amoxicillin     
 
 










B Membrane function Fungicidal 
  Nystatin Membrane function Fungicidal 
  Polymericin  Membrane integrity Bactericidal 
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Table.1.2: Reaction mechanism of antibiotics, the site of action being the 
Ribosomes. 
 
Site of Action Antibiotic 
Process 
Interrupted Type of Activity 
Ribosomes Chloramphenicol Protein synthesis Bactericidal 
 50s sub units Erythromycin Protein synthesis Bactericidal 
 30s sub units Aminoglycosides 
Protein synthesis 
and fidelity Bactericidal 
  
  












Cell division and micro 
tubules assembly Fungistatic 
DNA or RNA 
Mitomycin C  DNA synthesis Panicidal 
Refampin mRNA Bactericidal 
     
 
In many instances the mechanism of action is not fully known, for a few (e.g. 
penicillins) the site of action is known but precise details of the mechanism are 
still under consideration.  
 
The mechanism of action of an antibiotic determines, in general, whether the 
agent exerts a -cidal (killing) or static (holding) action. The distinction may be 
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important for the treatment of serious life-threatening infections particularly if the 
natural defense system of the host is either deficient or overwhelmed by 
infection. 
 
 In such a case a -cidal agent is obviously indicated but much work is to be done 
in this area and as mechanisms of actions are revealed, the development of 
improved structural analogues of effective antibiotics will continue to increase. 

-Lactam antibiotics (the class of amoxicillin): 
Antibiotics which contain the -lactam (a four membered cyclic amide) ring 
structure constitute the dominant class of antibiotic agent currently employed for 
the chemotherapy of bacterial infections (Gurdeep, R. Chatarwal, and Sham 
Anand: 2000. 5th). 
.  
The first antibiotic to be used in therapy of bacterial diseases was penicillin 
(penicillin G or benzyl penicillin) and a close biosynthetic relative phenoxymethyl 
penicillin remain the agents of choice for the treatment of infections caused by 
most species of Gram positive bacteria.  
 
The discovery of a second group of -lactam antibiotic the cephalosporins and 
the chemical modification of naturally occurring penicillins and cephalosporins 
have provided semi-synthetic derivatives that are variously effective against 
bacterial species known to be resistant to penicillin, in particular, penicillinase 
producing staphylococci and Gram negative bacilli.  
 
Hence, apart from a few resistant species that have either inherent or acquired 
resistance, almost all bacterial species are sensitive to one or more of the 
available -lactam antibiotics. 
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1.4.1. The Penicillins: 
Production of Penicillins: 
Until 1944, it was assumed that the active principal in penicillin was a single 
substance and that the variation in the activity of different products was due to 
the amount of inert material present in the sample (Gurdeep, R. Chatarwal, and 
Sham Anand: 2000. 5th). 
 
Now, it is known that during the biologic elaboration of antibiotics, several closely 
related compounds may be produced. These compounds differ chemically in acid 
moiety of the amide side chain. The difference in this moiety produces 
differences in the antibiotic activities of the various agents. This variation in 
moiety also affects the physicochemical properties. Thus it has become proper to 
speak of penicillins as a group of compounds and to identify each of penicillins 
specifically. As each of the different penicillins was first isolated letter 
designations were used in the United States; the British used Roman numerals. 
 
Many of the different kinds of penicillins have been isolated from fermentation 
mixtures. Some of these occur naturally while others have been biosynthesized 
by altering the cultural medium to provide certain be incorporated as acyl groups.  
The commercial production of biosynthetic penicillins today mainly depends on 
various strains of penicillium notatum and p-chrysogenum. In recent years, many 
more penicillins have been prepared semi-synthetically and undoubtedly many 
more will be added to the list to find more effective and valuable products. 
 
The commercial production of penicillin has increased markedly since its 
introduction. As its production increased, the cost dropped correspondingly. 
When penicillin became available for the first time, its 100,000 units were sold for 
20 dollars (Gurdeep, R. Chatarwal, and Sham Anand 2000: 5th). 
  
Fluctuations in the production of penicillin throughout the years have reflected the 
following changes. 
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 The popularity of broad spectrum antibiotics compared with penicillins 
 The development of penicillin resistant strains of several pathogens  
 The more recent introduction of semi-synthetic penicillin 
 The use of penicillins in animal foods and for veterinary purposes and 
 The increase in marketing problems in a highly competitive sales area. 
 
Allergic reactions to penicillins: 
Allergic reactions to various penicillins, ranging in severity and may include 
 A variety of skin and mucous membrane rashes 
 Drug fever (fever caused by a drug due to its allergic reaction)  
 Anaphylaxis (an acute multi-system allergic reaction) 
The penicillins most frequently implicated as the cause of allergic reactions are 
penicillin G and ampicillin. However, virtually all commercially available 
penicillins have been reported to cause such reactions. 
 
Classification of Penicillins: 
A number of designations have been used for classifying penicillins, based on 
their sources, chemistry, pharmacokinetic properties, resistance to enzymatic 
spectrum of activity and clinical uses. Therefore, keeping in view these 





















of Clinical use 
      Resistance Activity   
Benzyl 
penicillin Biosynthetic Poor No intermediate multi-purpose 
Phenoxymethyl Biosynthetic Good No intermediate multi-purpose 
Penicillin           
Methicillin 
semi-
synthetic Poor yes Narrow Limited 
Oxacillin 
semi-
synthetic Good yes Narrow Limited 
Dicloxacillin 
semi-
synthetic Good yes Narrow Limited 
Ampicillin 
semi-
synthetic Good no Broad multi-purpose 
Amoxicillin 
semi-
synthetic Good no Broad multi-purpose 
Peperacillin 
semi-
synthetic Poor no Extended Limited 
 
1.5. Amoxicillin: 
Amoxicillin is a semi-synthetic Penicillin, introduced in 1974 and is simply the p-
hydroxy analogue of Ampicillin (Sciencedirect 20007). It is prepared by the 
acylation of 6-APA (6-aminopenicillanic) with p-hydroxyphenylglycin. 
 
It is an antibiotic with a broad spectrum of bacterial activity that is used against 
many of the Gram-positive and few Gram-negative bacteria. Its antibacterial 
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spectrum is nearly identical to that of Ampicillin, and like Ampicillin, it is resistant 
to acids, susceptible to alkaline and -lactamase hydrolysis and is weakly protein 
bound.  
 
 Mode of action: 
It acts against bacterial activity by inhibiting the synthesis of bacterial cell walls. 
Amoxicillin stops the cross-linkage between the linear peptidoglycan polymer 
chains that make up a major component of the bacterial cell wall.   
 
 Physical Characteristics of Amoxicillin: 
 It is a white crystalline powder 
 Practically, odorless and tasteless.  
 It is sparingly soluble in water  
 Practically insoluble in ether, chloroform and fixed oils.  
 It dissolves in dilute solutions of alkali hydroxides. 
 
 Microbiology:  
Amoxicillin is a moderate-spectrum antibiotic active against a wide range of  
1. Gram-positive (Streptococcus spp, Non--lactamase producing 
Staphylococcus spp and Streptococcus faecalis). And  
2. Limited range of Gram negative bacteria (Haemophilus influenzae, 
Neisseria gonorrhoeae, Neisseria meningitides etc.). 
 
Resistant organisms: 
There are some microorganisms which offer resistance to the action of 
Amoxicillin such as penicillinase producing organisms (particularly penicillinase 
producing staphylococcus spp etc).  
 
However, Amoxicillin has been shown to eradicate the resistant organisms if its 
routinely given concentration (in pediatrics) is doubled (Red Book, 2003 Report 
of the Committee on infectious diseases, American Academy of Pediatrics). 
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Formulation: 
Amoxicillin is available in tri-hydrate form as capsules and syrups for oral use 
and in the form of the sodium salt for intravenous administration. 
 
Advantages of Amoxicillin over Ampicillin: 
Orally administrated Amoxicillin has some advantages over Ampicillin such as 
 More complete gastrointestinal absorption to give higher plasma and urine 
levels 
  Less diarrhea  
 Little or no effect of food on absorption.  
 
Thus amoxicillin has largely replaced ampicillin. However, amoxicillin is reported 
to be less effective than ampicillin in the treatment of bacillary dysentery, 
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Chapter 2: Theory of Analytical Techniques: 
The theory of analytical techniques such as High Performance Liquid 
Chromatography, Capillary Electrophoresis, Infrared Spectroscopy and Thin 
Layer Chromatography used for the analysis of amoxicillin will be discussed in 
this chapter. 
2.1. High Performance Liquid Chromatography (HPLC): 
 High performance liquid chromatography is an analytical technique used for the 
separation and determination of organic and inorganic solutes in any sample 
especially biological, pharmaceutical, food, environmental, industrial, etc.  
 
In the process of chromatography a liquid permeates through a porous solid 
stationary phase and elutes the solutes into a flow-through detector. The 
stationary phase is usually in the form small uniform particles with a diameter 
ranging from 5-10µm, packed into a cylindrical column. The typical column is 
made of a rigid material such as stainless steel or plastic and is generally 5-30 
cm long having internal diameter ranging from 1-9mm.  
2.1.1. HPLC System: 
In a typical HPLC system, a detector measures response changes between the 
solvent itself, and the solvent and sample electrical response is digitized and sent 
to a data system. An HPLC system comprises of the following parts. 
 
1. Solvent delivery system. It pushes the solvent stream through the       
instrument at a constant flow rate. 
2. Column. A stainless steel tube packed with silicon beads that separate 
the desired compound from the other compounds. 
3. Auto-sampler. It introduces the sample into the main liquid stream of the 
system.  
4. Detector. An optical sensor is fixed in the HPLC system that detects the 
changes in the characteristics of the solvent stream. 
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5. Data system. There is always a data system used as a means of     
controlling the system components and storing, processing and displaying 
the data. 
 
A high pressure is also fixed in the HPLC device to push the mobile phase 
through the column at a typical flow rate ranging from 0.1 to 2ml/min.The sample 
to be separated is introduced into the mobile phase system by an injection 
device, manual or automatic, prior to starting the analysis. A schematic diagram 
of HPLC system is shown in Figure 1.1. 
 
Figure.1.1: Various parts of HPLC system. 
 
Types of HPLC based on force of attraction: 
There are three main types of HPLC based on forces of attraction found between 
analyte, stationary phase and mobile phase. These types are 
 Charge based HPLC 
 Reverse phase HPLC  
 Normal phase HPLC 
 
Charge based HPLC is based on the forces of attraction found between 
oppositely charged particles. Charge based HPLC is of two types 
a) Ion pairing HPLC which involves smaller molecules  
b) Ion-exchange HPLC which involves relatively larger particles and 
the charge particles bend reversibly towards the sample molecules. 
This item has been removed due to 3rd Party Copyright. The unabridged 
version of the thesis can be viewed in the Lanchester Library Coventry 
University.
 22 
In charge based HPLC, the process of desorption is carried out by increasing the 
salt concentration or changing the pH of the mobile phase.  Charges involving 
charge based HPLC are 
 Inorganic anion such as Cl¯, Br¯ and SO4
¯2. 
 Inorganic cations 
 Organic acids 
 Organic bases 
 
Reversed phase HPLC involves the use of a non-polar stationary phase and a 
slightly polar mobile phase. It does not involve any ionic forces of attraction or 
any charged particles. The retention time for non-polar molecules is longer as 
compared for polar molecules having less retention time. The reversed phase 
HPLC works on the principle of interactions between relatively polar solvents, 
non-polar solvent and non-polar stationary phase. 
 
The third and simplest type of HPLC is the normal phase HPLC. This type of 
HPLC involves the use of a polar stationary phase and a non-polar mobile phase.   
 
Types of HPLC based on its Applications: 
HPLC has the following main types based on its applications. 
 
Preparative HPLC. This type of HPLC involves the isolation and purification of 
compounds. It provides information about the compound produced in the process 
of preparation. It is also used to obtain various informations such as 
identification, quantification and resolution of compounds.  
 
Type of HPLC based on chemical separation. This type of HPLC involves the 
separation of various chemicals using the difference between the migration times 
of compounds. This can be achieved by using suitable mobile phase and 
columns.  
HPLC based on purification. This type of HPLC involves the separation or 
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isolation of a desired or targeted compound from a mixture of other compounds 
or contaminants. Each substance produces a characteristic peak on HPLC 
apparatus which is used as a basis for purification of compounds. 
 
HPLC based on identification of compounds. This type of HPLC is set up 
identify a given compound or to identify each and every single compound in a 
mixture of compounds. The identification process needs suitable detectors and 
then the development of a separation assay. The desired peak produced for the 
compound to be identified should have the following characteristics. 
a. Reasonable retention time 
b. Repeatability of retention time and 
c. Well defined and separated from the other peaks. 
 
HPLC based on quantification. This type oh HPLC involves the determination 
of unknown concentration of a compound in known solution of known 
concentration. The process of quantification could be more easily understood by 
the calculations in the coming chapters. 
 
Current Developments: 
HPLC is one of the most useful lab-separation techniques used by analytical 
chemists. It is of enormous use not only these days but its present importance 
shows that this technique will gain more popularity and will further add to the 
ease of separation chromatography. It is more obvious that in the near future, 
HPLC will be used in the field of biotechnology and life sciences. LC-MS is 
another separation technique and is a combination of liquid chromatography and 
mass spectrometry. Biotechnology companies and pharmaceutical industries will 
be using HPLC for two main reasons. 
 
a) To assure the government and public that the products the produce are 
non-toxic  
b) The products they produce are always in their pure forms.  
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Furthermore, fast and micro bore columns will be used in pharmaceutical 
industries, biotechnology and environmental sciences to reduce the time period 
analysis. The light scattering detectors may replace the RI detectors in the near 
future. Another possibility is the use of robots to analyse hazardous samples 
such as AIDS, viral or bacterial samples, radio active isotopes or environmental 
contaminants.  
2.2. Advantages of HPLC: 
1. HPLC offers a higher resolution and greater speed of analysis. 
2. Greater reproducibility (+/- 1%) because of close control of the             
parameters affecting the efficiency of the separation. 
3. High sensitivity [ranging from nano gm (10-9) to femto gm (10-15)] 
4. It offers an easy automation of instrument operation and data analysis. 
5. HPLC columns can be reused without repacking or regeneration. 
6. Adaptability to large-scale, preparative procedures. 
2.2.1. Disadvantages of HPLC: 
1. HPLC is more expensive as compared to other analytical techniques. 
2. It is a complicated technique, this reason is one of it’s main demerit. 
3. HPLC shows low sensitivity towards the analysis of certain compounds. 
4. Irreversibly absorbed compounds cannot be detected. 










2.3. The Capillary Electrophoresis (CE): 
The process of electrophoresis is defined as “the differential movement or 
migration of ions by attraction or repulsion in an electric field.  
In practical terms, a positive (anode) and a negative (cathode) electrode are 
placed in a solution containing ions. Afterwards, voltage is applied across the 
electrodes, solute ions of different charges, such as anions which are the 
negatively charged ions and cation (positively charged ions) start moving through 
the solution towards the oppositely charged electrodes.  
 
Hence the capillary electrophoresis is the technique of performing 
electrophoresis in buffer filled narrow bored capillaries, normally ranging from 25 
to 100 micrometers in internal diameter. 
 
In its classical form, it is used to separate the mixtures of charged solute species 
by differential migration through a buffered electrolyte solution supported by a 
thin slab a short column of a polymeric gel such as polyacrylamide or agarose, 
under the influence of an applied electric field that creates a potential gradient.  
 
Two platinum electrodes are placed in an electrolyte which is contained in a 
reservoir at opposite ends of the supporting medium and then the electrodes are 
connected to an external DC power supply.  
 
A considerable amount of heat may be produced during the separation of 
components of a mixture at a higher applied voltage. To stabilize the 
temperature, many systems use water-cooling. As the process is carried out 
under the effect of an external applied electric field, the buffer solution undergoes 
electrolysis, a producing hydrogen and oxygen at cathode and anode 
respectively, and the have to be replenished or the buffer has to be renewed to 
maintain pH stability. 
 
Cationic solute species that are positively charged species migrate towards the 
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cathode and the anionic species having negative charge migrate towards anode, 
while the neutral species do not move at all and remain close to the point at 
which the sample was introduced to the system.  
2.3.1. Instrumentation of CE: 
The CE device is very simple in design. It features the following main parts. 
 
Injector: The first part of a CE device is the injector. It is used to introduce the 
sample into the capillary and may be accomplished using pressure or voltage. 
 
Capillary: Second part of a CE apparatus is narrow bore capillary. It is typically 
made of fused silica and can be fabricated from borosilicate as well. The surface 
charge of a capillary is important in affecting the electro-osmotic flow. 
 
Power Supply: Third part of the CE is a high voltage power supply. This source 
of power supply is used to apply voltage to cathodic or anodic reservoir when the 
reservoirs are grounded. A platinum electrode is used to connect the high voltage 
source to the capillary electrophoresis running buffer because of its relative 
inertness. 
 
Detector: Fourth part of the CE apparatus is a detector which is one of the most 
important parts of a CE apparatus. CE can be connected to a number of 
detection devices. Some of the most common detection devices are UV visible 
absorbance detection, laser induced fluorescence, mass spectrometry and 
electrochemical detection. UV absorbance detection is the most common and 
nearly universal technique used in CE analysis. 
 
Computer: Fifth part of the CE device is a computer. It is used to convert analog 
data output from the detector to digital format for software analysis. The software 
packages used to control the CE systems are mostly based on the existing HPLC 
software. 
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The sample is injected onto the capillary by temporarily replacing one of the 
buffer reservoirs (normally at the anode) with a sample reservoir and applying 
either an electric potential or external pressure for a few seconds.  
 
After replacing the buffer reservoirs, an electric potential is applied and hence the 
process of separation is performed. Optical (UV-visible or fluorometric) detection 
of the separated components of the analyte can be achieved directly through the 




Figure1.2: shows a typical capillary electrophoresis instrument. 
2.3.2. Theory of capillary electrophoresis: 
The theory of capillary electrophoresis explains the process of CE very 
successfully and is therefore, applied to CE device and can be show in the form 
of following equations. 
 
As the electrophoresis is the movement or migration of ions or solutes under the 
effect of an applied electric potential therefore, the separation depends on the 
migration velocities of ions or solutes to be separated and can be given as  
 
                                    = e E                             (a) 
Where  is ion migration velocity in m / sec, e is electrophoretic mobility in metre 
squared / V sec, and E is the electric field strength in V / m. 
This item has been removed due to 3rd Party Copyright. The unabridged 
version of the thesis can be viewed in the Lanchester Library Coventry 
University.
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This expression shows a balance of two opposite forces acting on the ion. These 
forces are, 
 Electrical force which favours the motion of  ion 
 Force of fraction which opposes the motion of ion 
The electrophoretic mobility is always constant as the forces acting on the 
moving ion balance each other, hence                                 
                                                  = q / 6 r                               (b) 
Where is the viscosity of the buffer, is a constant with a value of 3.14, q is the 
charge on the ion and r is the ion radius. 
 
This equation shows a relation between charge to mass ratio of an ion and the 
electrophoretic mobility. Charge q is always fixed for fully dissociated ions such 
as strong acids and small ions and can be affected by the pH alterations.  
 
Electro osmotic flow: 
The bulk flow of a liquid through a capillary under the influence of an applied 
electric force is called the electro-osmotic flow which is caused as follows. 
When the capillary of a CE is filled with buffer, it causes the following phenomena 
to take place. 
1. Negatively charge walls attract positive ions from the solution 
2. It causes a potential difference close to the capillary walls called zeta 
potential. 
According to the Stern model of electric double layer (consisting of rigid layer of 
adsorbed ions and a diffused layer), in which ion diffusion may occur due to 
thermal motion. When a voltage is applied across the capillary, cations in the 
diffused layer are free to migrate towards the cathode, carrying the bulk solution 
with them. The result is the net flow in the direction of the cathode, with a certain 
velocity given as under                      
                                        EOF = O/ 4              (c) 
Where O is the dielectric constant of a vacuum, is the dielectric constant of the 
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buffer,  is the zeta potential, is the viscosity of the buffer and E is the applied 
electric field. The terms enclosed in the brackets equate to the mobility of the 
EOF. 
The relationship between EOF mobility and EOF velocity is analogous to that 
between electrophoretic mobility and migration velocity. And also the units for 
EOF are the same as for the electrophoretic mobility. 
 
Applications of Capillary Electrophoresis: 
1. Pharmaceutical applications. Pharmaceutical industry uses capillary 
electrophoresis for a number of reasons and applies the CE technique to 
the assay of drugs, determination of drugs related impurities, analysis of 
small molecules and ions and the analysis of pharmaceutical products. 
Pharmaceutical industry uses capillary electrophoresis because of its low        
cost, reduced solvent consumption and disposal, and fast and speedy analysis. 
 
2. Food analysis. Capillary electrophoresis is used in the food analysis to 
maintain a high quality and known composition and for the detection of 
any contaminants if present. 
3. Chiral analysis. Keeping in view the chiral selectors, CE is applied to 
stereo selective analysis, soluble and chemically stable compounds 
analysis and efficient analysis of compounds with respect to their rapid 
complextaion kinetics. 
4. Analysis of vitamins. Capillary electrophoresis is successfully applied to 
the analysis of some vitamins as well. 
5. CE applied to environmental analysis. Capillary electrophoresis is newly 
introduced technique to environmental analysis. Capillary electrophoresis 
is used in environmental science for the analysis for the analysis of toxic 
and hazardous samples from waste sites. 
Capillary electrophoresis is used in analytical chemistry for polar volatile 
compounds, semi volatile and non-volatile compounds, inorganic cations and 
anions as well. 
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2.4. The infrared spectroscopy: 
It is one of the most useful and powerful techniques offering the possibility of 
chemical identification in analytical chemistry. It refers to the part of 
electromagnetic spectrum between the visible and microwave region.  
 
The most useful advantage of IR is that it is used to for the structure elucidation 
of molecules. The infrared spectroscopy is based on the fact that the sample 
under observation shows a well defined absorption in the IR region. 
 
The electromagnetic spectrum has waves of different length exhibiting different 
frequencies, therefore a possible relation between the wave length and 
frequency of these waves can be given as under 
 
                                       =    c/          and     = c/                          a 
 
Where  is the frequency of waves (number of wave cycles that pass through a 
point in one second). It is measured in Hertz, where 1 Hz = 1cycle/sec. 
 is the wave length of one complete  wave cycle and is often measured in cm. 
where c is the speed of light and is always a constant.  
Hence if c = constant then from equation    a 
 
                                                     =    constant /            or 
                                                        1/                         or 
                                                        1/    (c = constant)                 b 
 
Wave length  and frequency  are inversely related to each other, shorter the 
wave length higher the frequency and longer the wave length lower will be the 
frequency. 
Similarly, the energy E of the wave is related to the wave length     and 
frequency    by the following equations: 
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                                           E = h                                             c 
Where h is a constant called Plank’s constant and  is the frequency of the wave 
having energy E, but as we know that 
 
                                       = c/       from equation   a   hence by putting the value 
of frequency from equation a in equation c we get 
 
                                      E =hc/                                            d 
 
These two equations (c and d) show relationship between energy and frequency, 
and energy and wave length respectively. 
 
Equation c shows that energy E is directly related to the frequency of the waves, 
and from equation d, it is clear that energy E is inversely proportional to the wave 
length   as h is constant in both cases. 
 
                                        E   = constant               or 
                                        E                                similarly 
                                        E     = constant c/  
As         c = constant as well   then 
                                        E   = constant/                 or 
                                        E               1/ 
That shows the relationship   between energy, frequency and wave length. 
 
Different subdivisions of IR regions: 
Infrared region is further subdivided into the following regions 
 The near IR region also known as vibrational rotation region ranging from 
14000 cm -1 to 4000 cm -1 
This region is usefully applied in pharmaceutical analysis for raw material testing, 
product quality control and process monitoring. 
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 The mid IR region ranging from 4000 cm -1 to 400 cm -1 
 Far IR region ranging from 400 cm -1 to 10 cm -1 
2.4.1. Bond stretching: 
The atoms of covalently bonded molecules are not bonded through rigid bonds 
and the bonds are therefore, relatively flexible as the two nuclei are attracted by 
the same pair of electrons. Thus these nuclei can vibrate to and fro (backward 
and forward) towards and away from an average position. 
 
The phenomenon of bond stretching can be simplified with the help of the 
following diagram showing the stretching that occurs in carbon oxygen single 
bond. There will, of course, be other atoms attached to both carbon and oxygen. 
For example it could be the carbon and oxygen bond in methanol, CH3OH.                                                                                                                                                  
 
                                      H3C……….OH 
   
                                      H3C………………OH 
 
                                          H3C……….OH 
Figure .1.3: Vibrations due to bond stretching and contracting. 
 
The energy involved in this vibration depends on factors such as length of the 
bond and the mass of the atoms at either end.  The greater the bond length, the 
more easy will the vibration occur and vice versa. 
2.4.2. Molecular vibrations:  
The vibrations exhibited by molecules are called molecular vibrations. These 
vibrations are of two types. 
1. Stretching vibrations 
2. Bending vibrations 
In routine life while studying chemistry, one may think the molecules having rigid 
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and fixed bonds with rigid bond angles. But the actual case is not like this and is 
different from these imaginations because the bond lengths and the angles 
represent the average position about which the atoms vibrate.  
 
A non-linear molecule may have three rotational and two vibrational degrees of 
freedom. The remaining degrees of freedom correspond to fundamental 
vibrations. Similarly for linear molecules, there are two rotational and three 
translational degrees of freedom. 
 
The net numbers of fundamental vibrations for linear and non-linear molecules 
are mentioned in the following table. 
 
Table.1.5: Number of fundamental vibrations for linear and non-linear molecules. 
 




The fundamental vibrations of a molecule correspond to the number of bands in 
IR spectrum produced by that molecule (the actual number is some times 
different). The fundamental vibrations for water molecule (water is a linear 
molecule having three fundamental vibrations) are as under. 
 
                  
Symmetrical stretching     asymmetrical stretching       scissoring (bending) 
 
 Figure.1.4: Stretching and binding vibrational modes of H2O. 
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Carbon dioxide, CO2, is linear and hence has four fundamental vibrations as 
shown in the fig 4.3. Thus a symmetrical stretch of CO2 gives a strong band in 
the IR at 235 cm.-1The two scissoring and binding vibrations are equivalent and 
therefore, have the same frequency and therefore are said to be degenerate, 
appearing in the IR spectrum at 666 cm.-1 
 
                                                                                                                     
 
                    a = Symmetric stretching vibration of molecule AB2 
                    b = Asymmetric stretching vibration of the AB2 molecule.  
                    c = Symmetric stretching vibration of molecule AB2. 
                    d = Asymmetric stretching vibration of the AB2 molecule. 
 
Figure.1.5: Stretching and bending vibrational modes for CO2. 
The symmetrical stretch of CO2 is inactive in the IR because this vibration 
produces no change in the dipole moment of the molecule. In order to be IR 
active, a vibration must cause a change in the dipole moment of the molecule. 
2.4.3. Instrumentation of IR. 
The device used for IR analysis is called IR spectrometer. It has the following 
main parts. 
1. Light source. It is usually a tungsten halogen lamp. 
2. Detector. They are made of silicon, lead sulphide, Indium Gallium 
Arsenide. 
3. Monochromator. Used to separate the poly chromatic IR spectral region 
into monochromatic frequencies. 
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Before using IR for any analysis, it should be calibrated involving the following 
steps. 
1). Selection of representative calibration sample set. 
2). Spectra acquisition and determination of reference values. 
3). Multivariate modeling to relate the “spectral variations” to the reference 
values. 
4). Validation of the model by cross validation, set validation or external 
validation.       
 
                      
 
Figure.1.6: Shows schematic representation of FT.IR instrument. 
 
Applications of IR: 
The infrared technique very useful technique and is applied to the analysis of a 
large number of compounds. Some of its applications are discussed as follows. 
 
Combinations of IR with other analytical tools: 
IR technique can be applied more usefully by combining it with a number of other 
analytical tools. Some of these useful IR combinations are as follows. 
 
ATR-IR: Attenuated total reflectance technique is combined with IR to analyse 
solids, powders, pastes and liquids. This technique is very useful in studying the 
vapour-solid interactions during chemical vapour deposition and to study 
heterogeneous catalysis. 
 
DRIFTS-IR: DRIFTS is Diffuse Reflectance Infrared Fourier Transform 
This item has been removed due to 3rd Party 
Copyright. The unabridged version of the thesis can 
be viewed in the Lanchester Library Coventry 
University.
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Spectroscopy. This technique is used in surface chemistry studies of high 
surface area powders more usefully in heterogeneous catalysis. It is also used 
for the analysis of polymers. A combination of DRIFTS and near IR is applied to 
pharmaceutical analysis.  
 
Long Path Gas Cell: this technique involves an increase in the pathlength at a 
fixed concentration of a gas to get increased IR absorption signals and is used 
for the analysis of gases (FTIR 2008). 
 
Pharmaceutical applications of IR: 
IR did not develop very quickly to be used in the pharmaceutical industry, but still 
it has gained a good deal of popularity in pharmaceutical industry with respect to 
research, production and quality control.  Some of the most useful applications of 
IR in pharmaceutical analysis are listed below. 
 
a). Identifications of raw materials and intermediates 
b). Analysis of intact dosage form including the analysis of tablets and the 
analysis of capsules including both hard and soft capsules. 
 
Quantitative analysis applications of IR: 
It is based on the determination of one of the functional groups of the compound 
to be analyzed. The quantity is then calculated using Beer’s law. 
 
Draw backs of IR: 
IR has the following draw backs  
1. Sample cells are made of potassium or sodium chloride therefore the 
sample thickness may vary due to the following reasons 
a) Due to chemical attack from the solvent 
b) They are easily distorted as they are very soft 
2. As the Beer law is used for quantitative analysis using IR, therefore the    
results obtained may deviate from Beer law due to the following reasons 
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a) Variation of certain frequencies, shapes   and orientations. 
b) False measurements produced by the spectrometer of 
transmitted or absorption bands during some analysis. 
 
Limitations of IR: 
IR has some limitations as well. Some of the IR limitations are listed as under 
a) It can not be used to find the molecular weight of a substance (except 
under some certain conditions). 
b) Does not provide any information about the position of functional 
groups in a compound. 
c) IR of unknown compounds does not state that if it is a pure compound 
or a mixture of compounds. Although the IR has the draw backs and 
limitations as listed above, still it is advantageous in many ways. 
2.4.5. Advantages of IR 
a) Provides structural information about the structure of molecules 
b) Offers a shorter time of analysis (1 to 2 minutes)  
c) Minimal or no sample preparation is required prior to analysis. 
d) Nutritionally relevant parameters can be predicted. 
e) Many parameters can be assessed simultaneously. 
f) Minimal operator skills are required. 
2.4.6. Disadvantages of IR: 
IR has the following disadvantages 
a) The purity of a compound is difficult to be determined using a single IR 
spectrum of an unknown substance 
b) Infrared analyses are based on correlations derived from samples with 
known composition. 
c) It is not able to predict all the parameters, most importantly organic 
compounds present at concentrations below 1g / kg and minerals. 
d) IR equipment is quite expensive. 
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2.5. Thin layer chromatography: 
This section explains the theoretical concept of TLC, it’s experimental and it’s 
various applications. 
2.5.1. Experimental of TLC technique: 
The experimental technique of TLC comprises the following main components. 
1. Coating material: There is a large number of coating materials 
commercially produced for TLC coating. 
2. Preparation of thin layers: TLC thin layers are prepared in different ways 
by using the coating slurry in either way of pouring, spraying, spreading or 
using pre-coating plates. 
3. Activation of adsorbent: The adsorbent is activated by drying the plates 
in    air for 30 minutes and then in the oven for another 30 minutes. 
4. Sample application: It is usually done by using a micro-syringe (for 
quantitative analysis) and capillary tube for qualitative analysis. 
5. Development tank: The tank used in paper chromatography is also used 
in TLC. 
6. Solvent system: Solvent selection is very important for the TLC analysis 
is very important as different analysis needs different solvent. 
7. Development method: Normally ascending technique is used for 
developing TLC chromatograms. 
8. Detection of components: The methods of detecting the solutes which 
are used in paper chromatography are used in TLC as well. 
9. Evaluation of chromatogram: Evaluation of chromatogram is done either 
qualitatively or quantitatively. 
 
Applications of TLC: 
TLC has been applied very successfully to analyze various organic and inorganic 
compounds. Its success is mainly due to the properties which the TLC is popular 
for such as its application to the analysis of most of the chemical compounds, its 
high speed of separation and high selectivity. 
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Some of the most common and important applications of TLC are listed as under. 
 It is used to check the purity of sample compounds 
 It is used as a purification process  
 It is a useful tool for examining the reactions 
 It is also used to identify compounds 
 It is also used in quantitative analysis 
 
To gain the desired results in the analysis mentioned above, it is very        
important that the reaction is separable and sufficiently nonvolatile to remain on 
the plate during the development process and is not affected by the developing 
solvent and adsorbent. Following compounds are analysed by successful 
application of TLC. 
 
a) It is successfully applied to the analysis of organic acids, alcohols, glycols, 
alkaloids, amines and amino acids, proteins and peptides.  
b) It is applied to antibiotic analysis. 
c) It is used for the analysis of inorganic ions. 
2.5.3. Advantages of TLC: 
Following are some of the advantages which TLC has over the other 
chromatographic techniques. 
1. It is very simple technique 
2. It offers a shorter development time for the separation of inorganic 
adsorbent layers 
3. Wide choice of stationary phase 
4. Very early recovery of separated components 
5. Very easy visualization of separated components 
6. Extremely sharp spots are obtained for quantitative analysis 
7. It offers a variable thickness of thin layers  
8. Uses chemically inert stationary phase 
 
 40 
2.5.4. Limitations of TLC: 
The main limitation of TLC is that it is used only for small scale preparative 
works. It is highly desirable that the scale of operation should be increased 
without simultaneously sacrificing the resolving power. Some workers have 
obtained high resolution by using column chromatography while others have 























Chapter 3:   
“CE Method Development and Solvent Selection for the Analysis 
of Amoxicillin” 
 
Before analysing amoxicillin using capillary electrophoresis, it was necessary to 
develop a CE method suitable for good analysis and achieving good results e.g. 
repeatable and accurate. The details of developing a CE method for the analysis 
of amoxicillin are as follows. 
 
Initial CE conditions: The initial CE conditions used for the analysis of 
amoxicillin are listed in the Table 3. 
 
Table.3: Initial CE conditions for amoxicillin analysis. 
 
Solvent 50 % HPLC grade water / 50 % methanol 
Running buffer 
(mobile phase) 
0.02 M borate phosphate and 1.44% SDS 
adjusted to a pH 8.60 
Column Agilent technology (40 cm X 50 µm I.D)  
injecting pressure 50 mbar 
Applied voltage ranging from 15 kV to 30 kV 
Detection wavelength 214nm 
Lab temperature 25 Cº 
injection type Hydrodynamic 
 
 
3. Standard preparation 1: 
 
Standard stock solution of a 1000 ppm concentration was prepared by dissolving 
a weighed amount of standard amoxicillin in a solvent of 50 % HPLC grade water 
and 50 % HPLC grade methanol. The buffer used was 0.02M borate-phosphate 
supplemented with 1.44 % SDS having a pH range from 6.0 - 9.0. Finally the 
buffer was adjusted to a pH 8.60. 
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3.1. CE procedure 1: 
A 100 ppm solution was prepared by diluting the 1000 ppm stock solution. This 
100 ppm solution was then transferred to a CE vial through a dropper. The vial 
was then placed in its proper position in the CE apparatus and injection was 
performed at an injecting pressure of 50 mbars. 
 
The electropherogram obtained from the first injection, contained two narrow 
peaks (produced after 5.452 and 5.565 minutes) of equal heights by a difference 
of three seconds only. The standard was run for three times under the same 
conditions and the electropherograms obtained were the same as produced from 
the first injection. 
 




Figure.3. CE electropherogram for pure amoxicillin standard solution of 100 ppm 
in 50 % methanol / 50 % HPLC grade H2O at 15 kV. 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 5.452 0.042 100.8 33.63
2 5.565 0.041 94.55 32.99
total 195.3 66.62
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In order to get a single and well defined peak for amoxicillin standard solution, 
various parameters were changed one by one and it was observed that the 
electropherogram had the same two narrow peaks. The parameters which were 
changed during the analysis are listed below. 
 Voltage 
 Detection wavelength 
 Buffer pH and 
 Buffer composition  
 
Any changes in the above parameters had no effects on the peak produced. An 
electropherogram obtained at 18 kV is given in Figure 3.1. 
 
It is found that a change in voltage produces change in retention time and has 
no effects on the quality of peak. By increasing the voltage from 15 kV to 18 kV, 
the migration time decreased from 5.452 and 5.565 minutes to 4.445 and 4.534 
minutes.  
 
Figure.3.1: Electropherogram for 100 ppm Amoxicillin standard solution at 18 kV 
when all other experimental conditions were kept the same. 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 4.445 0.039 118.6 41.74
2 4.534 0.038 112.6 42.62
total 231.2 84.36
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3.1.1 The effects of solvent composition: 
After having tried changing different parameters, the solvent composition was 
slightly changed by the following two ways 
 
1. Increasing methanol by 10 % from 50 to 60 % and decreasing water by 
10 % from 50 to 40 %. 
2. Decreasing methanol by 10 % from 50 to 40 % and increasing water by 
10 % from 50 to 60 %. 
The increase in methanol percentage did not affect the peak. However, by 
decreasing the methanol percentage, it was found that one of the two narrow 
peaks became smaller. 
 
The percentage of methanol was further reduced such that the solvent 
composition was 60 % water / 40 % methanol, 80 % water / 20 % methanol. It 
was found that one of the two narrow peaks was considerably reduced. The 
electropherogram obtained at a reduced methanol concentration is given in 
Figure 3.1.1 on the following page. All other experimental conditions were kept 
the same as for previous CE injection. 
 
Figure.3.1.1: Electropherogram for 100 ppm Amoxicillin standard solution at the 
same experimental conditions when methanol concentration was lowered. 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 4.559 0.035 38.54 15.52
2 4.659 0.041 184.5 68.31
total 223 83.83
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Finally when standard solution was prepared in HPLC grade water only without 
adding any methanol, and was anlysed by CE, a well defined and single peak 
was produced. This lead to the conclusion that the peak doubling effect was due 
to the presence of methanol in the solvent composition and proved the water to 
be a solvent as used in the CE analysis of amoxicillin.  
 
The electropherogram obtained from the analysis of 100 ppm Amoxicillin 
standard solution at 18 kV contained a single well defined peak when the 
amoxicillin solution was made with only HPLC grade water. This solution did not 





Figure.3.1.2: electropherogram obtained for 100 ppm Amoxicillin standard 
solution under the same experimental conditions using only HPLC grade water 
as a solvent. 
3.1.2. Effects of change in voltage on migration time: 
A change in the voltage during the CE analysis of amoxicillin produced a 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 4.788 0.056 434.5 95.29
total 434.5 95.29
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prominent effect on the migration time. It was found that an increase in the 
voltage supply decreases the migration time and vice versa. The migration time 
noted at different voltages is listed in the following Table. 
 
Table.3.1: Effects of voltage on migration time. 
 
Voltage 13 kV 15kV 18kV 30kV 
Migration time (min) 7.195  6.390  4.736  2.463  
 
The effects of voltage on migration time can be better understood by viewing the 
electropherograms for 100 ppm Amoxicillin solution using different values of 




Figure.3.1.3. Electropherogram for 100 ppm amoxicillin solution observed at 18 
kV to show the effect of voltage on migration time. The initial migration time 
recorded is 4.788 minutes. 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)





Figure.3.1.4: Electropherogram for 100 ppm amoxicillin solution observed at 15 




Figure.3.1.5: Electropherogram for 100 ppm amoxicillin solution observed at a 
voltage of 13 kV. The retention time further increases as the voltage decreases. 
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 6.39 0.064 363.5 79.75
total 363.5 79.75
Number Migration Width Area Height
of peaks time (min) (min) (mAU) (mAU)
1 7.195 0.083 561.3 95.95
total 561.3 95.95
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It was concluded from the results observed in the electropherograms given 
above that a decrease in voltage produces an increase in the migration time i.e. 
decreasing the voltage, an increase in the migration time is observed and vice 
versa. 
3.1.3. Finalising CE Conditions for further Analysis: 
After the solvent was selected and having set all the parameters, the CE analysis 
of amoxicillin was undertaken by using the conditions given in the Table 3.1.1. 
 
Table.3.1.1: CE conditions for the analysis of Amoxicillin.  
 
Solvent HPLC grade water 
Running buffer 
0.02 M borate phosphate and 1.44% SDS adjusted to 
a pH 8.60 
Column Agilent technology (40 cm X 50 µm I.D)  
injecting pressure 50 mbar 
Applied voltage ranging from 15 kV to 30 kV 
Detection wavelength 214nm 
lab temperature 25 Cº 
injection type Hydrodynamic 
 
 
All the standard amoxicillin solutions of different concentrations and all amoxicillin 












Chapter 4:             “Experimental Procedures” 
This chapter comprises of the designation of all the experimental procedures for 
the analysis of antibiotic amoxicillin. 
 
The antibiotic amoxicillin was analysed using the following analytical techniques. 
 Capillary Electrophoresis  
 High Performance Liquid Chromatography 
 Infrared Spectroscopy  
4.1. Capillary Electrophoresis of Amoxicillin: 
Capillary electrophoresis experiments were carried out on Agilent CE system, 
equipped with a power supply of 30kV, and a UV spectrophotometer detector 
connected to a data collection system. The system was able to perform both 
hydrodynamic and voltage injection. 
 
Reagents and Standards: 
Pure Amoxicillin tri-hydrate (of 97% purity) was obtained from Aldrich. Sodium 
phosphate, sodium tetra borate, sodium hydroxide and phosphoric acid were of 
reagent grade. Sodium Dodecyl sulfate (SDS) was provided by Aldrich. Water 
used to prepare standard and sample solutions, and the running buffers were 
also obtained from Aldrich. Samples analysed were obtained from different parts 
of subcontinent and the Middle East. All the samples were weighed and then the 
same samples were analysed on HPLC, CE and IR. These samples are listed in 









Table.4: Amoxicillin samples. 
 
Amoxicillin Sample  Pharmaceutical company 
Maxil 500 mg Macter International, Karachi, Pakistan 
Werrimox 500 mg Werrick Pharmaceuticals, Islamabad, Pakistan 
Amoxicillin 500 mg Pliva Pakistan, Baluchistan, Pakistan 
Effimox 500 mg Wilson’s Pharmaceuticals, Islamabad, Pakistan 
Namoxil 500 mg  Nawan Laboratories, Karachi, Pakistan 
Amoxascot 500 mg Scotmann Pharmaceuticals, Islamabad, Pakistan 
Medimox 500 mg Medicraft Pharmaceuticals, Hayatabad, Peshawar 
Pakistan 
Labmox 500 mg Laborate Pharmaceuticals, India  
HMC 250 mg H-Tech International enterprises, Hayden Beijing, China 
Acamoxil 250 mg ACAI Pharmaceuticals, Iraq  
Glomox 500 mg Glow expert trading, Mumbai, India 
 
Standard preparations: 
Standard stock solution of a 1000 ppm (1000 mg / l) concentration was prepared 
by dissolving a weighed amount of standard amoxicillin in HPLC grade water. 
The buffer used was 0.02 M borate-phosphate having a pH range from 6.0-9.0, 
supplemented with 1.44 % SDS. Finally the buffer was adjusted to a pH 8.60. 
 
CE conditions: 
The CE analysis of Amoxicillin was undertaken by using the following conditions 








Table.4.1: CE conditions for the analysis of Amoxicillin. 
 
Solvent HPLC grade water 
Running buffer 
0.02 M borate phosphate and 1.44 % SDS adjusted 
to a  pH 8.60 
Column Agilent technology (40 cm X 50 µm I.D)  
injecting pressure 50 mbar 
Applied voltage ranging from 15 kV to 30 kV 
Detection wavelength 214nm 
lab temperature 25 Cº 





A 100 ppm solution was prepared by diluting the 1000 ppm stock solution. This 
100 ppm solution was then transferred to a CE vial through a dropper. The vial 
was then placed in its proper position in the CE apparatus and injection was 
performed at an injecting pressure of 50 mbars and detection wave length of 214 
nm. 
 
Determination of migration time (Mt) for standard solutions: 
Once a suitable CE method was developed for the analysis of Amoxicillin, CE 
injection was performed for all the standard solutions (300 ppm, 200 ppm, 150 
ppm, 100 ppm and 50 ppm) one by one and the migration times for all the 
standards were recorded and tabulated as under in Table 4.1.1. 
 
Table.4.1.1: Migration times recorded for various Amoxicillin standards solutions. 
 
amoxicillin standards 50 ppm 100 ppm 150 ppm 200 ppm 300 ppm
migration time (min) 4.759 4.673 4.768 4.775 4.681  
 
The effect of voltage on migration time was previously discussed that voltage 
inversely affects migration time. The slight variations in migration time noted for 
different concentrations of amoxicillin standard solutions is due to the slight 
 52 
variation in room temperature which also can affect the voltage supply and 
varying migration time. 
 
Migration time variation was also observed when the buffer efficiency decreases 
because of repeated CE analysis. The migration time did not show any further 
variation when the temperature was kept constant by air conditioning the CE lab 
and by changing the buffer vials frequently. 
 
Sample preparation: 
Eleven samples from different countries were collected and then three capsules 
form each sample were analysed. All the samples were in capsule form and their 
contents were directly analysed without any further purification. Masses of the 
sample capsules were recorded using an analytical balance. Then 0.10 g of each 
capsule was taken in three separate 50 cm3 volumetric flasks and the sample 
solutions were prepared to these volumes using the HPLC grade water as a 
solvent.  
 
The sample solutions were then placed in an ultrasonic bath for achieving a 
complete dissolution. After getting dissolved the samples, the sample solutions 
were then centrifuged to separate any solid sample particles left in the solutions. 
The reason for centrifugation was to protect the narrow capillary from being 
blocked by small solid particles in the sample solution.   
 
Sample injection and migration times of samples: 
Once all the sample solutions were ready, they were analysed by CE and their 
migration times were noted. Standard solutions of pure amoxicillin of different 
concentrations (500 ppm, 1000 ppm, 1500 ppm, 2000 ppm and 2500 ppm) were 
always analysed before analysing each sample solution. The migration times 




Table.4.1.2: Migration times recorded for Amoxicillin samples. 
 
Amoxicillin samples Migration time in minutes 
Maxil 500 mg 4.696 min 
Werrimox 500 mg 4.708 min 
Amoxicillin 500 mg 4.819 min 
Effimox 500 mg 4.693 min 
Namoxil 500 mg  4.957 min 
Amoxascot 500 mg 4.840 min 
Medimox 500 mg 4.761 min 
Labmox 500 mg 4.701 min 
HMC 250 mg 4.652 min 
Acamoxil 250 mg 4.671 min 
Glomox 500 mg 4.628 min 
 
 
The migration times noted for all the Amoxicillin samples are almost the same. 
The minor differences found between the migration times are probably due to 
slight variation of temperature of laboratory during analysis. Migration time 
variation was also observed when the buffer efficiency decreases because of 
repeated CE analysis. The migration time did not show any further variation 
when the temperature was kept constant by air conditioning the CE lab and by 









4.2. HPLC Analysis of Amoxicillin: 
A review of literature revealed that several High Performance Liquid 
Chromatography methods have been reported for the individual identification and 
quantification of amoxicillin in the sample or determination of amoxicillin in a 
mixture of other compounds. 
 
Here, the method used is an isocratic reversed phase HPLC method for the 
determination of amoxicillin in the sample capsules using Kontron 320 HPLC 




HPLC chromatographic system consisted of a pump equipped with a 50 l loop, 
ultraviolet variable wavelength detector. All the chromatographic separations 
were achieved on an Ultra C18 column (150 mm x 4.6mm I.D) as a stationary 
phase. 
 
Reagents and chemicals: 
Standard amoxicillin was purchased from Aldrich (of 97 % purity) and was used 
without any further purification. HPLC grade water and HPLC grade methanol 
was purchased from sigma and used to prepare all the standards. 
 
Chromatographic conditions: 
All the chromatographic conditions for the analysis of Amoxicillin are given in the 








Table.4.1.3: Chromatographic conditions for HPLC analysis of Amoxicillin. 
 
solvent / mobile phase60 % HPLC grade water / 40 % methanol
Column C - 18
Elution Isocratic reverse phase
Flow rate 1 ml / min
Wavelength 230 nm
Temperature Room temperature (20 Cº to 25 Cº)  
 
Standard preparations: 
A standard Amoxicillin solution (stock solution) of 1000 ppm (1000 mg / l) was 
prepared by dissolving a weighed amount of pure Amoxicillin in the solvent 
having same composition as the mobile phase mentioned above. 
 
Standard solutions of Amoxicillin having concentrations of 30 ppm, 20 ppm, 
15ppm, 10 ppm and 5 ppm were prepared by diluting the 1000 ppm solution 
(stock solution) using the same solvent. 
 
Selection of detection wavelength for Amoxicillin: 
In order to select the wavelength to be used by the UV detector of HPLC, a UV 
spectrum of pure Amoxicillin (standard solution of 100 ppm) was obtained using 
a UV spectrometer. The UV spectrometer was set at a wave length ranging from 
190 nm to 400 nm. The optimum wave length found for pure Amoxicillin was 230 











Figure.4: UV spectrum shown by amoxicillin standard solution of 100 ppm at a 
wavelength ranging from 190 nm to 400 nm. 
 
Where  
                                                                               
Determination of retention time (Rt) for standard solutions: 
Once the detection wavelength was selected, all the Amoxicillin standard 
solutions (30 ppm, 20 ppm, 15 ppm, 10 ppm and 5 ppm) were injected on to the 
HPLC system one by one and the retention times for all the standard solutions 
were recorded and are given in the Table 4.1.4.  
Table.4.1.4: Retention times recorded for various Amoxicillin standards solutions 
(variation found is probably due to the variation in laboratory conditions). 
 
amoxicillin standards 5 ppm 10 ppm 15 ppm 20 ppm 30 ppm
retention time (min) 4.99 4.84 4.98 5.11 5.01  
 








A = amoxicillin and mobile phase
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amoxicillin standard solutions is not same and shows a slight variation. The 
retention time depends on temperature, contamination build up in the column and 
flow rate. As the flow rate remains the same throughout the analysis therefore, 
this minor variation is probably due to the change in room temperature and 
contamination which builds up due to repeated analysis without flushing the 
capillary out.  
 
If the HPLC laboratory temperature is kept constant and capillary is flushed with 
mobile phase regularly between each two analysis, the retention time noted for 
different concentrations of standard solutions of the same compound should 
remain the same. 
 
Sample preparation: 
Eleven samples from different countries were collected and then three capsules 
from each sample were analysed. All the samples were in capsule form and their 
contents were directly analysed without any further purification. Masses of the 
sample capsules were recorded using an analytical balance. Then 0.10 g of each 
capsule was taken in three separate 50 cm3 volumetric flasks and the sample 
solutions were prepared to these volumes using the mobile phase as a solvent. 
In order to dissolve the sample completely and get clear sample solutions, the 
sample solutions were sonicated until clear solutions were prepared. 
 
Sample injection and retention time: 
After preparing completely dissolved sample solutions, these solutions were 
injected onto the HPLC system one by one and retention times were then noted 
for each sample solution. Standard solutions of pure amoxicillin having different 
concentrations (200 ppm, 400 ppm, 600 ppm, 800 ppm and 1000 ppm)  were 
also injected as a reference before injecting the samples every time. 
 
The retention times recorded for amoxicillin samples are listed in the Table 4.1.5 
on the following page. 
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Table.4.1.5: Retention times recorded for Amoxicillin samples. 
 
Amoxicillin samples Retention time in minutes 
Maxil 500 mg 4.203 minutes 
Werrimox 500 mg 4.215 minutes 
Amoxicillin 500 mg 4.243 minutes 
Effimox 500 mg 4.238 minutes 
Namoxil 500 mg  4.23 minutes 
Amoxascot 500 mg 4.22 minutes 
Medimox 500 mg 4.198 minutes 
Labmox 500 mg 4.195 minutes 
HMC 250 mg 4.361 minutes 
Glomox 500 mg 4.712 minutes 
Acamoxil 250 mg 4.238 minutes 
 
 
Table 4.1.5 shows that there is a slight variation in retention times noted for 
different brands of amoxicillin samples. Some of the samples eluted slightly 
faster than the others. The reason for this change in retention time was the 
changing temperature of the HPLC lab. When the samples were analysed at 
constant laboratory temperature, the retention time noted for all the samples was 
same (4.22 minutes to 4.23 minutes). 
 
Second cause for this slight change in retention time was the contamination build 
up by repeated sample analysis without flushing the column after each sample 
injection. When the column was flushed with solvent in between each two 
analysis, the retention time noted for all the amoxicillin samples was the same 





4.3. The Infrared Spectroscopy of Amoxicillin: 
The infrared spectroscopy of amoxicillin was carried out using the IR 
spectrophotometer (Nicolet 210) for recording spectra consisting of a light 
source, monochromator and a detector. 
 
Standards and Reagents:  
Potassium bromide, Standard amoxicillin tri-hydrate of 97% purity was purchased 
from Aldrich. The samples analysed have already been listed in the beginning of 
this chapter and were obtained from Middle East and Subcontinent. 
 
Preparation of samples:  
The method used for the preparation of samples was the disc method. Before 
analysing the samples of various brands of amoxicillin, pure amoxicillin was 
analysed by IR. The disc formation for pure amoxicillin is as follows. 
 
1 mg of pure amoxicillin was mixed with 100 mg of potassium bromide. The 
mixture was ground and was pressed under a high pressure of about 800 MPa 
until a small round transparent disc was formed. The disc was then placed within 
the appropriate holder FT – IR spectrometer and scanned between 4000 cm−1 
and 400 cm−1. The disc method described above for the IR analysis of pure 
amoxicillin was used for the analysis of different brands of amoxicillin samples. 
 
The spectrum obtained can be explained with the help of assigning absorbance 
to their respective functional groups in amoxicillin as each functional group 
shows a characteristic absorbance at a particular wave length as shown in the 

















The IR peaks observed for pure Amoxicillin are marked with arrows and are 
assigned to their respective functional groups. These are listed in the Table 
4.1.7. 
 
Table.4.1.7: List of IR peaks absorbance for pure Amoxicillin as assigned to their 
respective functional groups. 
 
Peak. No  Functional Group Absorbance  
1 Cyclic amide 3457.98 cm−1 
2 ═C─H in aromatic ring 3166.91 cm−1 
3 ─CH3 3036.89 cm
−1 
4 ─CH3 2969.12 cm
−1 
5 ─C═O stretching in cyclic amide  1775.03 cm−1 
6 ─C═O stretching in normal amine 1686.41 cm−1 
7 N─H bending in normal amine 1615.91 cm−1 
8 Skeletal stretch in aromatic ring 1451.30 cm−1 
9 ─CH3 of ─CH3─CO by the ring 1396.37 cm
−1 
10 C─O─C    in ─CO2H 1248.96 cm
−1 




The bands in 800--600 cm−1 appear due to the bending of the ─C─H bond. The 
bands in the region from 1600—1500 cm−1 appear due to C═C bond of the 
aromatic ring. Whereas, the rest of the spectrum can be regarded as a 
“fingerprint” of the entire amoxicillin structure. 
 
All the samples were analysed following the same procedure as mentioned 
above. The spectrum for each of the sample amoxicillin was recorded and two 
characteristic strong peaks were observed at 1775 cm−1 and 1686 cm−1 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
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Chapter 5:  “Results and Discussions” 
This chapter includes the results produced from the analysis of different brands 
of antibiotic Amoxicillin. The results for each of the samples will be discussed in 
this chapter. A list of all the samples is given on the following Table.  The HPLC, 
CE and IR results are discussed together for each sample. The results are listed 
according to the sample number given in the list in the form of Table 4. 
 







1 Maxil 500 mg Macter International, Karachi, Pakistan 
2 Werrimox 500 mg Werrick Pharmaceuticals, Islamabad, 
Pakistan 
3 Amoxicillin 500 mg Pliva Pakistan, Baluchistan, Pakistan 
4 Effimox 500 mg Wilson’s Pharmaceuticals, Islamabad, 
Pakistan 
5 Namoxil 500 mg  Nawan Laboratories, Karachi, Pakistan 
6 Amoxascot 500 mg Scotmann Pharmaceuticals, Islamabad, 
Pakistan 
7 Medimox 500 mg Medicraft Pharmaceuticals, Hayatabad, 
Peshawar, Pakistan 
8 Labmox 500 mg Laborate Pharmaceuticals, India  
9 HMC 250 mg H-Tech International enterprises, Hayden, 
Beijing, China 
10 Acamoxil 250 mg ACAI Pharmaceuticals, Iraq  





The amount of amoxicillin in all samples was calculated for both CE and HPLC 
methods after calibration curves were obtained for different amoxicillin standard 
solutions with the analysis of every single sample. The calibration curves (drawn 
for calculating the amount of amoxicillin in sample 1a after HPLC analysis) for 
various concentrations of amoxicillin standard solutions are given in the Figure 
5.1a. 
 
Figure.5: Calibration Curves for amoxicillin standard solutions of different 





The calibration curves (drawn for calculating the amount of amoxicillin in sample 
1a after CE analysis) for various concentrations of amoxicillin standard solutions 
are given in the Figure 5 on the following page. 
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Figure.5.1a: Calibration Curves for amoxicillin standard solutions of different 




Calibration curve obtained for different standard solutions of amoxicillin shows a 
linear rise from lower to higher concentrations. Calibration curves were obtained 
for all the samples to find the amount of amoxicillin in the sample capsules. 
The amount of amoxicillin in each of the sample capsule (after CE analysis) was 
calculated using the following equation 
 
                                                  y = b x + a                                     (1) 
Where “y” is the peak area, “x” is the concentration, “b” is the slope and “a” being 
the intercept on the y-axis. 
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Now for sample 1a, the amount of amoxicillin after CE analysis was calculated 
using equation 1.   
 
From the calibration curve given in the Figure 5  
y = 0.367 x + 6.79                                   (where 0.367 = b   and 6.79 = a) 
 
But      y = 635.132       (area of the peak produced by sample 1a during CE)  
Putting the values in equation 1 we get     635.132 = 0.367 x + 6.79 
 
Or                                                                      x = 635.132 ─ 6.79 / 0.367  
 
                                                                          x = 1723.8149 
 
As x = no of µg of amoxicillin in 1 ml of sample solution. Therefore 
 
No of µg of amoxicillin in 1 ml of sample solution = 1723.8149 µg 
 
No of µg of amoxicillin in 50 ml of sample solution = 50 x 1723.8149 
 
                                                                                 x = 86190.745 µg 
 
                                          Value of x in mg                = 86.1907 mg 
 
                                           Value of x in gm               = 0.08619 gm 
 
No of gm of amoxicillin in 0.10 gm of sample   = 0.08619 gm 
No of gm of amoxicillin in 0.630 gm of sample = 0.630 x 0.08619 / 0.10 
= 0.542997 gm 
        = 0.543 gm 
                                                                             = 543 mg 
 
The amount of amoxicillin for all the other sample capsules from different brands 
of amoxicillin was calculated using the method as described above for sample 
capsule 1a. Same method for the calculation of the amount of amoxicillin in the 







Three capsules from sample Maxil were analysed and were designated as 
sample 1a, 1b and 1c. 
 
Table.5.1. CE results produced by Maxil sample capsules.    
 
  Total weight Amoxicillin Migration Amoxicillin Number 
  of sample per capsule Time Per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
1a 630 500 4.69 543 3 
1b 630 500 4.72 531.3 3 
1c 619 500 4.7 514.79 3 
Average 627.7 500 4.70 529.69 3.00 
St Dev 7.8 0.0 0.02 11.57 0.00 
 
Each individual sample capsule was analysed three times repeatedly under the 
same experimental conditions and the results recorded every time for each 
individual capsule were the same and the standard deviation calculated for the 
migration time of each sample was almost equal to zero.  The value of standard 
deviation suggests that repeatability exists within the sample capsules. 
 
Table 5.1 shows that sample Maxil 1a and 1b contain amoxicillin in excess 
amount compared to the claimed quantity of 500 mg amoxicillin per sample 
capsule, similarly Maxil sample capsule 1c also contains excess amoxicillin as 
compared to the claimed amount of 500 mg of amoxicillin per sample capsule.   
 
It is also found that the calculated amounts of amoxicillin per sample capsule are 
not the same in all the sample capsules analysed. Therefore, a variation in 
content uniformity within the brand is observed.  
 
The average amount of amoxicillin per sample capsule comes to 529.69 mg 
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which is still a higher value as compared to the claimed amount of amoxicillin per 
sample capsule. Despite of slightly higher calculated values of amoxicillin per 
sample capsule compared to the stated amount, these samples meet the 




HPLC results obtained from the analysis of capsules 1a, 1b and1c from sample1 
(Maxil) are listed in Table 4.1a. 
 
Table.5.1a: Results obtained from the HPLC analysis of sample Maxil. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time Per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
1a 630 500 4.73 544.6 3 
1b 630 500 4.77 529.45 3 
1c 619 500 4.72 517.66 3 
Average 627.66 500.0 4.74 530.57 3.00 
St Dev 6.34 0.0 0.03 + 11.02 0.00 
 
All the three sample capsules were analysed three times repeatedly under the 
same experimental conditions and the results recorded every time for each 
individual capsule were the same. This suggested the individual capsules highly 
repeatable. 
 
Table 5.1a indicates higher values of amoxicillin for all the three Maxil sample 
capsules as compared to the claimed amount of 500 mg amoxicillin per sample 
capsule. The average value comes to be 530.57 mg of amoxicillin per capsule of 
Maxil sample.  
 
It is also found that the calculated amounts of amoxicillin per sample capsule are 
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not the same in all the sample capsules analysed. Therefore, a variation in 
content uniformity within the brand is observed. The results suggest that all the 
sample capsules contained the amount of amoxicillin within the acceptable limits 
of international standards of quality control and therefore of good standard. 
 
A comparison of CE and HPLC results for sample 1 is given in Figure 5.  
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Figure.5.1a: Bar chart showing a comparison of CE and HPLC results for 
sample 1. 
 
Figure 5.1 shows slightly higher values of amoxicillin calculated per sample 
capsule by CE method compared to HPLC. The reason for the difference 
between the HPLC and CE results has not been investigated due to time limits 
for the project.  
 
IR results: 
For further conformation of contents, IR analysis of sample 1 was undertaken 
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and the spectrum obtained was compared with the IR spectrum of pure 
amoxicillin. The various peaks observed are listed in Table 5.1b. 
 
Table.5.1b: comparison between strong IR peaks of amoxicillin sample Maxil 
and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample 1a 1686.34 cm-1 1775.21 cm-1 
3 Sample 1b 1686.35 cm-1 1775.01 cm-1 
4 Sample 1c 1686.37 cm-1 1775.09 cm-1 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Maxil 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 1 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: The retention and migration time recorded (from HPLC and CE 
respectively) for all the capsules from sample 1 agree the retention and migration 
time recorded for pure amoxicillin and also the IR spectra produced by capsules 
from sample 1 strongly correspond to the IR spectrum of pure amoxicillin. This 
confirms the presence of amoxicillin in sample 1.   
 
The HPLC and CE analysis show that sample 1 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer which 
meets the international standards of quality control and thus did not show any 
counterfeiting.  
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Sample.2. Werrimox  
 
CE results: 
Three capsules from sample Werrimox were analysed and were designated as 
sample 2a, 2b and 2c. 
 
Table.5.2: CE results produced by Werrimox sample capsules.  
 
   
  Total weight Amoxicillin Migration amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
2a 598 500 4.7 513.45 3 
2b 657 500 4.71 521.6 3 
2c 579 500 4.68 518.26 3 
Average 611.3 500.0 4.70 518.6 3.00 
St Dev 40.7 0.0 0.02 5.3 0.00 
  
 
Each individual sample capsule was analysed three times and the results 
produced by each individual sample were the same. Standard deviation 
calculated for migration time noted for each individual sample capsule was 
almost equal to zero suggesting that repeatability exists within the sample 
capsules. 
 
As the calculated amount of amoxicillin in the sample capsules of the same 
brand is not equal and shows variation between the sample capsules, hence a 
variation in content uniformity is observed. 
 
Table 5.2 indicates higher values of amoxicillin for all the three Werrimox sample 
capsules as compared to the claimed amount of 500 mg amoxicillin per sample 
capsule. The average value comes to be 518.57 mg of amoxicillin per capsule of 
Werrimox sample. The results suggest that all the sample capsules contained the 
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amount of amoxicillin within the acceptable limits of international standards of 
quality control and therefore of good standard. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 2a, 2b and 2c from sample 
2 (Werrimox) are listed in Table 4.2a. 
 
Table.5.2a: HPLC results for sample Werrimox. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
2a 611 500 4.78 523.72 3 
2b 587 500 4.73 514.35 3 
2c 593 500 4.73 514.21 3 
Average 597.0 500.0 4.75 517.4 3.00 
St Dev 12.5 0.0 0.03 5.5 0.00 
 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.2a indicates higher values of amoxicillin for all the three Werrimox 
sample capsules as compared to the claimed amount of 500 mg amoxicillin per 
sample capsule. The average value comes to be 517.42 mg of amoxicillin per 
capsule of Werrimox sample. The average calculated amount of amoxicillin per 
sample capsule is a higher value indicating the excess usage of raw material in 
the manufacturing process of amoxicillin.  
 
Furthermore, sample 2a has higher value of amoxicillin as compared sample 2b 
and 2c therefore there is a variation in content uniformity within the same brand 
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of amoxicillin sample. The results produced by all the three sample capsules 
meet the international standards of quality control and thus were found of good 
standard. 
 
A comparison of HPLC and CE results for sample 2 is given in Figure 5.2. 
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Figure.5.2: Comparison of CE and HPLC results for sample 2. 
 
Figure 5.2 shows almost higher values of amoxicillin calculated per sample 
capsule by CE method compared to HPLC with exception of capsule 2a which 
shows higher value calculated by HPLC as compared to CE results. The reason 
for the difference between the HPLC and CE results has not been investigated at 
this level of study.  
 
IR results: 
For further conformation of contents, IR analysis of sample 2 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 
amoxicillin. The various peaks observed are listed in Table 5.2b on the following 
page. 
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Table.5.2b: comparison between strong IR peaks of amoxicillin sample 
Werrimox and pure amoxicillin 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample 2a 1686.27 cm-1 1775.13 cm-1 
3 Sample  2b 1686.63 cm-1 1775.06 cm-1 
4 Sample 2c 1686.43 cm-1 1774.84 cm-1 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Werrimox 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 2 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 2 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 2 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 2.   
 
The HPLC and CE analysis show that sample 2 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meet 








Three capsules from sample Amoxicillin were analysed and were designated as 
sample 3a, 3b and 3c. 
 
Table.5.3: CE results produced by Amoxicillin sample capsules. 
 
  Total weight Amoxicillin Migration amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
3a 611 500 4.81 507.56 3 
3b 600 500 4.71 531.72 3 
3c 629 500 4.67 523 3 
Average 613.3 500.0 4.73 520.76 3.00 
St Dev 11.95 0.0 0.07 9.98 0.00 
 
Each individual sample capsule was analysed three times and the standard 
deviation calculated for the migration time noted for each sample was almost 
equal to zero. This value of standard deviation suggests that repeatability exists 
within the sample capsules. 
 
It was found that repeatability exists within the individual capsules but not 
between the capsules of the same brand because the amount of amoxicillin 
calculated per sample capsule is not the same throughout the samples and shows 
variation. 
 
Table 5.3 shows that the amount (507.56 mg) calculated for amoxicillin in sample 
3a, is slightly higher than the claimed quantity of 500 mg amoxicillin per sample 
capsule. However, sample capsule 3b and 3c show higher values as compared 
to the claimed amount of 500 mg amoxicillin per sample capsule.  
 
The average amount of amoxicillin per sample capsule comes to be 520.76 mg 
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amoxicillin per sample capsule which is still a higher value as compared to the 
claimed amount but all these value are within the limits of international standards 
of quality control and therefore, the samples are of acceptable standard.  
 
HPLC results: 
HPLC results obtained from the analysis of capsules 3a, 3b and 3c from sample 
3 (Amoxicillin) are listed in Table 4.3a. 
 
Table.5.3a: HPLC results for sample Amoxicillin. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
3a 611 500 4.69 509.43 3 
3b 600 500 4.75 528.13 3 
3c 629 500 4.77 519.74 3 
Average 613.33 500.0 4.74 519.1 3.00 
St Dev 11.95 0.0 0.04 7.64 0.00 
 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
The results listed in Table 5.3a show that sample 3a contained a slightly higher 
amount of amoxicillin than the claimed quantity of 500 mg amoxicillin per sample 
capsule. Samples 3b and 3c are found to contain excess amount of amoxicillin 
compared to the claimed amount of 500 mg amoxicillin per sample capsule. 
 
The average value of the individual calculated values of Amoxicillin per sample 
capsule comes to be 519.16 mg which is a higher value but all these value are 
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within the limits of international standards of quality control and therefore, the 
samples are of acceptable standard. 
 
A chart is given in Figure 2.1.7 showing a comparison of CE and HPLC results 
for sample 3. 
 











3a 3b 3c average



































CE HPLC amount claimed
 
 
Figure.5.1.1: Bar chart representing comparison of HPLC and CE for sample 3. 
 
Figure 5.1.1 shows almost higher values of amoxicillin calculated per sample 
capsule by CE method compared to HPLC with exception of capsule 3a which 
shows higher value calculated by HPLC as compared to CE results. The reason 
for any difference between the HPLC and CE results has not been investigated 
due to time limits for the project.  
 
IR results: 
For further conformation of contents, IR analysis of sample 3 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 
amoxicillin. The various peaks observed are listed in Table 5.3b on the following 
page. 
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Table.5.3b: Comparison between strong IR peaks of amoxicillin sample 
amoxicillin and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.41 cm-1 1775.03 cm-1 
2 Sample 3a 1686.43 cm-1 1774.97 cm-1 
3 Sample 3b 1686.27 cm-1 1775.23 cm-1 
4 Sample 3c 1686.26 cm-1 1774.97 cm-1 
 
The characteristic strong peaks observed at 1775.03 cm-1 and 1686.41 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and sample amoxicillin confirming 
the presence of ─C═O in cyclic amide structure and ─C═O in normal amine 
group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 3 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: The retention and migration time recorded (from HPLC and CE 
respectively) for all the capsules from sample 3 agree the retention and migration 
time recorded for pure amoxicillin and also the IR spectra produced by capsules 
from sample 3  strongly correspond to the IR spectrum of pure amoxicillin. This 
confirms the presence of amoxicillin in sample 3.   
 
The HPLC and CE analysis show that sample 3 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meet 






Sample.4. Effimox  
 
CE results: 
Three capsules from sample Effimox were analysed and were designated as 
sample 4a, 4b and 4c. 
 
Table.5.4: CE results produced by Effimox sample capsules. 
 
  Total weight Amoxicillin Migration Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
4a 593 500 4.69 509.64 3 
4b 591 500 4.71 527 3 
4c 618 500 4.74 523.76 3 
Average 600.7 500.0 4.71 520.1 3.00 
St Dev 15.0 0.0 0.03 9.2 0.00 
 
 
Each individual sample capsule was analysed three times and the standard 
deviation calculated for migration time noted for each sample was almost equal 
to + 0. This value of standard deviation suggests that repeatability exists within 
the sample capsules. 
 
Furthermore, it is seen that these calculated amounts of amoxicillin in the sample 
capsules are not the same for all the capsules of the same brand. Therefore, it 
suggests that repeatability is found within the individual sample capsules but not 
between the capsules. 
 
Table 5.4 shows that all the three Effimox sample capsule show higher values of 
amoxicillin as compared to claimed quantity of 500 mg amoxicillin per sample 
capsule.  
 
The average calculated amount of amoxicillin per sample comes to be 520.12 mg 
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amoxicillin per sample capsule of Effimox which meets the international standards 
of quality control. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 4a, 4b and 4c from sample 
4 (Effimox) are listed in Table 4. 
 
Table.5.4a: HPLC results for sample Effimox. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
4a 593 500 4.78 511.53 3 
4b 591 500 4.81 519.67 3 
4c 618 500 4.73 516.27 3 
Average 600.7 500.0 4.77 515.8 3.00 
St Dev 15.0 0.0 0.04 3.33 0.00 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.4a shows that all the three Effimox sample capsule show higher values 
of amoxicillin as compared to claimed quantity of 500 mg amoxicillin per sample 
capsule.  
 
The average calculated amount of amoxicillin per sample comes to be 515.82 mg 
amoxicillin per sample capsule of Effimox which is a bit higher value of 
amoxicillin per sample capsule but is within the limits of international quality 
standards. 
A comparison of CE and HPLC results is given in the Figure 2.1.8 on the 
following page. 
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Figure.5.1.2: Bar chart representing comparison of CE and HPLC for sample 4. 
 
Figure 5.1.2 shows almost higher values of amoxicillin calculated per sample 
capsule by CE method compared to HPLC with exception of capsule 4a which 
shows similar results produced by HPLC and CE analysis. The reason for the 
difference between the HPLC and CE results has not been investigated at this 
level of study.  
 
IR results: 
For further conformation of contents, IR analysis of sample 4 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 







Table.5.4b: Comparison between strong IR peaks of amoxicillin sample Effimox 
and pure amoxicillin 
 
S.No   Absorb.(max) −1   Absorb.(max) −2 
1 Pure Amoxicillin 1686.41 cm-1 1775.10 cm-1 
2 Sample 4a 1686.43 cm-1  1775.15 cm-1 
3 Sample 4b 1686.49 cm-1 1774.96 cm-1 
4 Sample 4c 1686.26 cm-1 1774.97 cm-1 
 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.41 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Effimox 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 4 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 4 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 4 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 4.   
 
The HPLC and CE analysis show that sample 4 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 







Three capsules from sample Namoxil were analysed and were designated as 
sample 5a, 5b and 5c. 
 
Table.5.5: CE results produced by Namoxil sample capsules. 
                                  
  Total weight Amoxicillin Migration Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
5a 572 500 4.95 511.78 3 
5b 545 500 4.83 521.66 3 
5c 655 500 4.96 528 3 
Average 590.7 500.0 4.91 520.5 3.00 
St Dev 46.80 0.0 0.07 6.67 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
Table 5.5 shows that all the three Namoxil sample capsule show higher values of 
Amoxicillin as compared to claimed quantity of 500 mg Amoxicillin per sample 
capsule. The average calculated amount of Amoxicillin per sample comes to be 
520.5 mg Amoxicillin per sample capsule of Namoxil which meets the international 
standards of quality control. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 5a, 5b and 5c from sample 
5 (Namoxil) are listed in Table 4.5a given on the following page. 
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Table.5.5a: HPLC results for sample Namoxil. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
5a 572 500 4.76 514.68 3 
5b 545 500 4.75 521.97 3 
5c 655 500 4.73 527.1 3 
Average 590.7 500.0 4.75 521.3 3.00 
St Dev 46.80 0.0 0.02 5.09 0.00 
 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.5a shows that all the three Namoxil sample capsules show higher values 
of Amoxicillin as compared to claimed quantity of 500 mg Amoxicillin per sample 
capsule. The average calculated amount of Amoxicillin per sample comes to be 
521.3 mg Amoxicillin per sample capsule of Namoxil which meets the 
international standards of quality control. 
 
A comparison of CE and HPLC is given in the Figure 5.1.3 on the following page. 
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Figure.5.1.3: Bars showing comparison of CE and HPLC results for sample 5. 




For further conformation of contents, IR analysis of sample 11 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 
amoxicillin. The various peaks observed are listed in Table 5.5b. 
 
Table.5.5b: Comparison between strong IR peaks of amoxicillin sample Namoxil 
and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.17 cm-1 
2 Sample  5a 1686.27 cm-1 1775.13 cm-1 
3 Sample  5b 1686.63 cm-1 1775.06 cm-1 
4 Sample  5c 1686.43 cm-1 1774.84 cm-1 
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The characteristic strong peaks observed at 1775.17 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Namoxil 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 5 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 5 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample  5 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 5.   
 
The HPLC and CE analysis show that sample 5 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 






















Sample.6. Amoxascot  
 
CE results: 
Three capsules from sample Amoxascot were analysed and were designated as 
sample 6a, 6b and 6c. 
 
Table.5.6: CE results produced by Amoxascot sample capsules. 
 
  Total weight Amoxicillin Migration amoxicillin number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
6a 615 500 4.84 556.92 3 
6b 611 500 4.79 558 3 
6c 571 500 4.96 460 3 
Average 599.0 500.0 4.86 525.0 3.00 
St Dev 19.86 0.0 0.09 45.94 0.00 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
The variation in content uniformity exists within the same brand and Table 5.6 
shows that sample Amoxascot 6a and 6b contain more Amoxicillin than the 
claimed quantity of 500 mg Amoxicillin per sample capsule.  
 
Sample capsule 6c contains less Amoxicillin as compared to the claimed amount 
of 500 mg of Amoxicillin per sample capsule. All the results are still within the 
limits of international standards of quality control. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 6a, 6b and 6c from sample 
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6 (Amoxascot) are listed in Table 4.6a. 
 
Table.5.6a: HPLC results for sample Amoxascot. 
 
  Total weight Amoxicillin Retention  amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
6a 615 500 4.95 558.92 3 
6b 611 500 4.83 557.06 3 
6c 571 500 4.96 458.94 3 
Average 599 500.0 4.91 525.0 3.00 
St Dev 19.86 0.0 0.07 46.67 0.00 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.6a shows that sample Amoxascot 6a and 6b contain more Amoxicillin 
than the claimed quantity of 500 mg Amoxicillin per sample capsule. Sample 
capsule 6c contains less amoxicillin as compared to the claimed amount of 500 
mg of Amoxicillin per sample capsule.  
 
The average calculated amount of Amoxicillin per sample capsule is 525 mg 
which is a higher value as compared to the claimed amount of 500 mg 
Amoxicillin per sample capsule. All these values meet the international standards 
of quality control. 
 
A comparison of CE and HPLC results is given in the form of the Figure 5.1.4 on 
the following page. 
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Figure.5.1.4: Bars showing comparison of CE and HPLC results for sample 6. 




For further conformation of contents, IR analysis of sample 6 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 
amoxicillin. The various peaks observed are listed in Table 5.6b. 
 
Table.5.6b: Comparison between strong IR peaks of amoxicillin sample 
Amoxascot and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure  Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample  6a 1686.29 cm-1 1775.15 cm-1 
3 Sample  6b 1686.63 cm-1 1775.03 cm-1 
4 Sample 6c 1686.47 cm-1 1774.86 cm-1 
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The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample 
Amoxascot confirming the presence of ─C═O in cyclic amide structure and 
─C═O in normal amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 6 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 6 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 6 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 6.   
 
The HPLC and CE analysis show that sample 6 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meet 




















Sample.7. Medimox   
 
CE results: 
Three capsules from sample Medimox were analysed and were designated as 
sample 7a, 7b and 7c. 
 
Table.5.7: CE results produced by Medimox sample capsules. 
 
  Total weight Amoxicillin migration amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
7a 562 500 4.76 493.53 3 
7b 602 500 4.75 517.38 3 
7c 550 500 4.73 508.47 3 
Average 571.3 500.0 4.75 506.5 3.00 
St Dev 22.23 0.0 0.02 9.83 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
However, the amounts of active ingredients found in all the samples are not the 
same and a variation in content uniformity exists within the same brand.  
 
Capsule 7b and 7c show are found to contain higher values of amoxicillin per 
capsule as compared to the claimed amount of 500 mg Amoxicillin per sample 
capsule. The average amount of amoxicillin per sample capsule comes to be 
506.4 mg which is slightly higher than the mentioned or claimed quantity and 




HPLC results obtained from the analysis of capsules 7a, 7b and 7c from sample 
7 (Medimox) are listed in Table 4.7a on the next page. 
 
Table.5.7a: HPLC results for sample Medimox. 
 
  Total weight Amoxicillin Retention  amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
7a 562 500 4.84 496.47 3 
7b 602 500 4.76 519.44 3 
7c 550 500 4.79 503.57 3 
Average 571.3 500.0 4.80 506.5 3.00 
St Dev 22.23 0.0 0.04 9.60 0.00 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.7a shows that the sample capsule Medimox 7a contains less amoxicillin 
as compared to the claimed quantity of 500 mg Amoxicillin per sample capsule. 
Capsule 7b and 7c show are found to contain higher values of amoxicillin per 
capsule as compared to the claimed amount of 500 mg Amoxicillin per sample 
capsule. 
 
The average amount of amoxicillin per sample capsule comes to be 506.4 mg 
which is slightly higher than the mentioned or claimed quantity but is in the limit 
of international standards of quality control. 
 
A comparison of CE and HPLC results for sample 7 is given in the Figure 5.1.5. 
on the following page. 
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Figure.5.1.5: Bars showing comparison of CE and HPLC results for sample 7. 
 
Figure 5.1.5 shows that the HPLC and CE results obtained from the analysis of 
sample 7 are nearly the same with small differences for capsules 7a (CE value 
slightly lower than HPLC) and capsule 7c (CE value slightly higher than HPLC). 
The reason for the difference between the HPLC and CE results has not been 
investigated at this level of study. 
 
IR results: For further conformation of contents, IR analysis of sample 7 was 
undertaken and the spectrum obtained was compared with the IR spectrum of 








Table.5.7b: Comparison between strong IR peaks of amoxicillin sample 
Medimox and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample  7a 1686.27 cm-1 1775.13 cm-1 
3 Sample  7b 1686.63 cm-1 1775.06 cm-1 
4 Sample 7c 1686.43 cm-1 1774.84 cm-1 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Medimox 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 7 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: The retention and migration time recorded (from HPLC and CE 
respectively) for all the capsules from sample 7 agree the retention and migration 
time recorded for pure amoxicillin and also the IR spectra produced by capsules 
from sample 7 strongly correspond to the IR spectrum of pure amoxicillin. This 
confirms the presence of amoxicillin in sample 7.   
 
The HPLC and CE analysis show that sample 7 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 






Sample.8. Labmox  
 
CE results: 
Three capsules from sample Labmox were analysed and were designated as 
sample 8a, 8b and 8c. 
 
Table.5.8: CE results produced by Labmox sample capsules. 
 
  Total weight Amoxicillin migration Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
8a 565 500 4.7 509.58 3 
8b 580 500 4.7 496.43 3 
8c 551 500 4.69 512.83 3 
Average 565.3 500.0 4.70 506.28 3.00 
St Dev 11.84 0.0 0.01 7.09 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
Table 5.8 shows that the sample capsule 8b is found to have slightly lower value 
of amoxicillin as the claimed amount of 500 mg amoxicillin per sample capsule, 
while sample capsules 8a and 8c show higher amounts of amoxicillin above the 
claimed amount of 500 mg amoxicillin per sample capsule. 
 
The average calculated value of amoxicillin per capsule is found to be 506.28 mg 
which is lower than the claimed amount of 500 mg amoxicillin / sample capsule. 




HPLC results obtained from the analysis of capsules 8a, 8b and 8c from sample 
8 (Labmox) are listed in Table 4.8a. 
 
Table.5.8a: HPLC results for sample Labmox. 
  Total weight Amoxicillin Retention  amoxicillin number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) repeats 
8a 565 500 4.77 516.83 3 
8b 580 500 4.73 498.73 3 
8c 551 500 4.76 507.64 3 
Average 565.3 500.0 4.75 507.7 3.00 
St Dev 11.84 0.0 0.02 7.38 0.00 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.8a shows that the sample Labmox capsule 8b is found to have very 
slightly lower value of Amoxicillin than the claimed amount of 500 mg Amoxicillin 
per sample capsule, while sample capsules 8a and 8c show higher amount of 
Amoxicillin above the claimed amount of 500 mg Amoxicillin per sample capsule. 
 
The average calculated value of Amoxicillin per capsule is found to be 507.73 mg 
which is higher than the claimed amount of 500 mg Amoxicillin / sample capsule. 
All the results produced by sample 8 are according to international standards of 
quality control. 
 
A comparison of CE and HPLC results is given in the Figure 5.1.6 on the 
following page. 
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Figure.5.1.6: Bar chart showing comparison of CE and HPLC results for sample 
8. 
 
Figure 5.1.6 indicates higher values of amoxicillin calculated HPLC compared to 
CE for capsules 8b and 8c, while CE results for capsule 8a are lower as 
compared to HPLC results and the average value calculated for CE and HPLC is 
found to be the same. The reason for any difference between the HPLC and CE 
results has not been investigated due to time limits for the project.  
 
IR results: 
For further conformation of contents, IR analysis of sample 8 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 





Table.5.8b: Comparison between strong IR peaks of amoxicillin sample Labmox 
and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure  Amoxicillin 1686.32 cm-1 1775.11 cm-1 
2 Sample  8a 1686.24 cm-1 1775.17 cm-1 
3 Sample  8b 1686.61 cm-1 1775.09 cm-1 
4 Sample 8c 1686.45 cm-1 1774.81 cm-1 
 
 
The characteristic strong peaks observed at 1775.11 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Labmox 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 8 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 8 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 8 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 8.   
 
The HPLC and CE analysis show that sample 8 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 




Sample .9. HMC  
 
CE results: 
Three capsules from sample HMC were analysed and were designated as 
sample 9a, 9b and 9c. 
 
Table.5.9: CE results produced by HMC sample capsules. 
 
  Total weight Amoxicillin migration Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
9a 296 250 4.65 254.63 3 
9b 307 250 4.64 256.86 3 
9c 293 250 4.63 248.65 3 
Average 298.7 250.0 4.64 253.38 3.00 
St Dev 6.01 0.0 0.01 3.46 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
Table 5.9 shows that capsule 9a from sample HMC is found to contain a slightly 
higher value of amoxicillin than the claimed amount of 250 mg amoxicillin per 
capsule. 
 
 Sample capsule 9c is found to contain slightly less Amoxicillin than the claimed 
quantity while sample capsule 9b is found to contain 256.86 mg amoxicillin which 
is slightly higher than the claimed amount of 250 mg amoxicillin per sample 




Each individual capsule show a good standard of repeatability but it is found that 
the amount of amoxicillin is not the same in all the sample capsules analysed. A 
variation in content uniformity is found within the same brand of amoxicillin. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 9a, 9b and 9c from sample 
9 (HMC) are listed in Table 4.9a. 
 
Table.5.9a: HPLC results for sample HMC. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule Time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
9a 296 250 4.78 257.84 3 
9b 307 250 4.78 261.73 3 
9c 293 250 4.76 253.63 3 
Average 298.7 250 4.77 257.7 3.00 
St Dev 6.01 0.0 0.01 3.3 0.00 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.9a shows that all the three HMC sample capsules show higher values of 
amoxicillin as compared to claimed quantity of 500 mg amoxicillin per sample 
capsule.  
 
The average calculated amount of Amoxicillin per sample comes to be 257.73 
mg Amoxicillin per sample capsule of HMC which meets the international 




The comparison of CE and HPLC results is given in the Figure 5.1.7. 
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Figure.5.1.7: Bars showing comparison of CE and HPLC results for sample 9. 
 
Figure 5.1.7 shows that, for the HPLC analysis of sample 9, the calculated values 
of amoxicillin per sample capsule are higher for all the sample capsules as 
compared to the values calculated by using CE technique. The reason for the 
difference between the HPLC and CE results has not been fully investigated due 
to time limits for the project.  
 
IR results: 
For further conformation of contents, IR analysis of sample 9 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 








Table.5.9b: Comparison between strong IR peaks of amoxicillin sample HMC 
and pure amoxicillin. 
 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample  9a 1686.27 cm-1 1775.13 cm-1 
3 Sample  9b 1686.63 cm-1 1775.06 cm-1 
4 Sample 9c 1686.43 cm-1 1774.84 cm-1 
 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample HMC 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 9 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 9 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 9 
strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 9.   
 
The HPLC and CE analysis show that sample 9 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 




Sample .10.  Acamoxil  
 
CE results: 
Three capsules from sample Acamoxil were analysed and were designated as 
sample 10a, 10b, and 10c. 
 
Table.5.1.1: CE results produced by Acamoxil sample capsules. 
 
  Total weight Amoxicillin migration Amoxicillin Number 
  of sample per capsule time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
10a 278 250 No peak 0 3 
10b 284 250 4.67 235.57 3 
10c 282 250 4.65 257.63 3 
10d 289 250 4.65 247.98 3 
Average 283.3 250.0 4.66 247.06 3.00 
St Dev 3.96 0.0 0.01 9.02 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
Table 5.1.1 shows that Acamoxil sample capsule 10b is found to contain less 
amoxicillin than the claimed amount of 250 mg amoxicillin per sample capsule 
but still meets the international standards of quality control. 
 
The sample capsule 10a is found to contain no amoxicillin at all. These results 
were confirmed by analysing the contents of sample capsule 10a repeatedly for 
five times under the same experimental conditions. The results produced were 
 103 
the same having no Amoxicillin peaks. The electropherogram obtained for 
sample capsule 10a was similar to the electropherogram produced by the 
analysis of pure water (HPLC grade water) only. This confirmed that sample 
capsule 10a did not contain any active ingredients and was a substandard or 
counterfeit sample. 
 
Further investigations were made by analysing another capsule from the same 
sample, designated as 10d. This sample capsule produced the same results as 
sample 10b and 10c confirming that sample capsule 10a did not contain any 
amoxicillin. The CE electropherograms produced by HPLC grade water and 
sample capsule  





Figure.5.2.7: CE electropherogram for HPLC H2O. NO peak was observed for 




Figure.5.2.8: CE electropherogram for sample capsule 10a. No peak was 
observed for sample 10 a. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 10a, 10b and10c from 
sample10 (Acamoxil) are listed in Table 4.1.1a. 
  
Table.5.1.1a: HPLC results. 
 
  Total weight Amoxicillin Retention  Amoxicillin Number 
  of sample per capsule time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
10a 278 250 No peak 0 3 
10b 284 250 4.77 237.87 3 
10c 282 250 4.73 258.21 3 
10d 289 250 4.76 246.76 3 
Average 283.3 250.0 4.75 247.61 3.00 
St Dev 3.96 0.0 0.03 8.32 0.00 
 
All the four sample capsules were analysed three times repeatedly using HPLC 
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under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
By studying Table 5.1.1a it is clear that no peak was recorded for sample 10a 
and suggests containing no amoxicillin. Sample10b is found to contain less 
amount of amoxicillin per sample capsule as compared to the claimed amount of 
250 mg per sample capsule. Sample 10c shows a slightly higher value of 
amoxicillin (but meets the international standards of quality control), while sample 
10d produces the results that are very close to the claimed quantity of 250 mg 
amoxicillin per sample capsule.   
 
The average value of the calculated amounts is 247.61 mg amoxicillin per 
sample capsule. This value is a very low calculated amount as compared to the 
amount of 250 mg amoxicillin per sample capsule as mentioned or claimed by 
the manufacturer. 
 
A comparison of CE and HPLC results for sample 10 is given in the Figure 5.1.8 
on the following page. 
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Figure.5.1.8: Bars showing comparison of CE and HPLC results for sample 10. 
 
Figure 5.1.8 shows that, the results produced by sample 10 using HPLC and CE 
are almost the same for all the capsules with only minor differences. The reason 
for the difference between the HPLC and CE results has not been investigated 
due to time limits for the project.  
 
IR results: 
For further conformation of contents, IR analysis of sample 11 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 







Table.5.1.1b: Comparison between strong IR peaks of amoxicillin sample 
Acamoxil and pure amoxicillin. 
S.No   Absorb.(max) −1  Absorb.(max) −2 
1 Pure amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample  10b 1686.27 cm-1 1775.13 cm-1 
3 Sample  10c 1686.63 cm-1 1775.06 cm-1 
4 Sample 10d 1686.43 cm-1 1774.84 cm-1 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and amoxicillin sample Acamoxil 
confirming the presence of ─C═O in cyclic amide structure and ─C═O in normal 
amine group respectively. The rest of the medium and weak peaks observed in 
IR spectrum of sample 10 were also compared to those observed in IR spectrum 
of pure amoxicillin and were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample 10 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 
10 strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 10.   
 
However, the HPLC and CE analysis show that one capsule from sample 10 did 
not contained any amoxicillin and was found blank. The average amount of 
amoxicillin per sample capsule was very less as compared to the stated amount 
of 250 mg amoxicillin per capsule. These results suggest sample 10 as 
counterfeit and substandard. As all other sample capsules from sample 10 
contained the relative exact amount of amoxicillin stated by the manufacturer, 
therefore, it follows the possibility for sample 10 to be counterfeited along the 
distribution chain (may have been repacked or one of the original capsules may 
have been replaced with a blank capsule without any active ingredients).   
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Sample .11. Glomox  
 
CE results: 
Three capsules from sample Glomox were analysed and were designated as 
sample 11a, 11b and 11c. 
 
Table.5.1.2: CE results produced by Glomox sample capsules. 
  Total weight Amoxicillin migration Amoxicillin Number 
  of sample per capsule time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
11a 549 500 4.62 523.64 3 
11b 598 500 4.65 518.45 3 
11c 566 500 4.55 522.82 3 
Average 571.0 500.0 4.61 521.6 3.00 
St Dev 20.31 0.0 0.05 2.27 0.00 
 
 
Each individual sample capsule was analysed three times under the same set of 
experimental conditions and the amount calculated each time was the same. 
This repeated analysis of sample capsules proved that there is no variation of 
composition within the individual sample capsules and that they show a high 
degree of repeatability. 
 
Table 5.1.2 shows that all the three Glomox sample capsule show slightly higher 
values of amoxicillin as compared to claimed quantity of 500 mg amoxicillin per 
sample capsule. The average calculated amount of amoxicillin per sample comes 
to be 521.64 mg amoxicillin per sample capsule of Glomox which meets the 
international standards of quality control. 
 
HPLC results: 
HPLC results obtained from the analysis of capsules 11a, 11b and 11c from 
sample11 (Glomox) are listed in Table 4.1.2a on the following page. 
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Table.5.1.2a: HPLC results for sample Glomox. 
 
  Total weight Amoxicillin Retention  amoxicillin Number 
  of sample per capsule time per capsule Of 
    (as stated)   (as sampled)   
  (mg) (mg) (min) (mg) Repeats 
11a 549 500 4.81 515.32 3 
11b 598 500 4.78 517.73 3 
11c 566 500 4.74 517.43 3 
Average 571.0 500.0 4.78 516.8 3.00 
St Dev 20.31 0.0 0.04 1.07 0.00 
 
 
All the three sample capsules were analysed three times repeatedly using HPLC 
under the same experimental conditions and the results recorded every time for 
each individual capsule were the same. This proved the individual capsules 
highly repeatable. 
 
Table 5.1.2a shows that all the three Glomox sample capsule show slightly higher 
values of amoxicillin as compared to claimed quantity of 500 mg amoxicillin per 
sample capsule. The average calculated amount of amoxicillin per sample comes 
to be 516.82 mg amoxicillin per sample capsule of Glomox which meets the 
international standards of quality control and hence the sample is of good quality 
and is not found to be counterfeited. 
 
A comparison of CE and HPLC results is given in the Figure 5.1.9 on the 
following page. 
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Figure.5.1.9: Bars showing comparison of CE and HPLC results for sample 11. 
 
Figure 5.1.9 shows higher calculated values of amoxicillin per sample capsule 
using CE as compared to the HPLC analysis of the same sample (sample 11) 
with the exception of sample capsule 11b showing the same CE and HPLC 
results. The reason for the difference between the HPLC and CE results has not 
been fully investigated due to the time limits for the project. 
 
IR results: 
For further conformation of contents, IR analysis of sample 11 was undertaken 
and the spectrum obtained was compared with the IR spectrum of pure 






Table.5.1.2b: Comparison between strong IR peaks of amoxicillin sample 
Glomox and pure amoxicillin. 
 
S.No   Absorb.(max)−1  Absorb.(max) −2 
1 Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
2 Sample  11a 1686.27 cm-1 1775.13 cm-1 
3 Sample  11b 1686.63 cm-1 1775.06 cm-1 
4 Sample 11c 1686.43 cm-1 1774.84 cm-1 
 
The characteristic strong peaks observed at 1775.10 cm-1 and 1686.32 cm-1 were 
recorded in the IR spectrum of pure amoxicillin and compared with IR spectrum 
of amoxicillin sample Glomox confirming the presence of ─C═O in cyclic amide 
structure and ─C═O in normal amine group respectively. 
 
The rest of the medium and weak peaks observed in IR spectrum of sample 11 
were also compared to those observed in IR spectrum of pure amoxicillin and 
were found the same. 
 
Summary: 
The retention and migration time recorded (from HPLC and CE respectively) for 
all the capsules from sample11 agree the retention and migration time recorded 
for pure amoxicillin and also the IR spectra produced by capsules from sample 
11 strongly correspond to the IR spectrum of pure amoxicillin. This confirms the 
presence of amoxicillin in sample 11.   
 
The HPLC and CE analysis show that sample 11 contained relevant amount of 
amoxicillin more or less the exact amount stated by the manufacturer and meets 





Comparison of results from HPLC and CE analysis of all the amoxicillin 
samples. 
The average or mean values of the individual calculated amounts for all 
Amoxicillin samples are compared for HPLC and CE analysis and are listed 
below. 
 
Table.5.1.3: Comparison of average amounts of all the samples as calculated 










+ average STDEV + 
  (mg) (mg) (mg)   (mg)   
Maxil 530.57 529.69 500  0.88 530.13 0.11 
Werrimox 517.42 518.57 500  1.15 517.99 0.57 
Amoxicillin 519.16 520.76 500  1.6 519.96 0.8 
Effimox 515.82 520.12 500  4.3 517.97 2.15 
Namoxil 521.3 520.48 500  0.82 520.89 0.41 
Amoxascot 524.49 524.49 500  0 524.49 0 
Medimox 506.4 506.4 500  0 506.4 0 
Labmox 507.73 506.28 500  1.45 507.0 0.72 
Glomox 516.82 521.64 500  4.82 519.23 2.41 
HMC 257.73 253.38 250  4.35 255.56 2.17 
Acamoxil 185.71 185.29 250  0.42 185.5 0.21 
 
 
All the average calculated amounts listed in the above Table are the amounts of 
amoxicillin per sample capsule for each brand of amoxicillin analysed by HPLC 
and capillary electrophoresis. Observation of Table 5.1.3 shows that the average 
calculated amounts of amoxicillin for most of the samples analysed by HPLC are 
slightly different than average calculated amounts as a result of their CE 
analysis.  
 
Some of the samples have almost or exactly the same average values of 
calculated amounts of amoxicillin per sample, by both the HPLC and CE 
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analysis, such as sample Namoxil, Amoxascot and Medimox show the same 
values of average calculated amounts of Amoxicillin per sample capsule when 
analysed by both HPLC and CE techniques. Similarly sample Werrimox 
produces almost the same results by both HPLC and CE analysis with a small 
difference of + 1.15 mg.  
 
The reason for the differences found between the HPLC and CE results has not 
been investigated due to limited time frame for the project.  
5.1: Quantitative comparison of different brands of amoxicillin 
samples: 
The CE and HPLC results for all the different brands were compared separately 
such that the CE results are compared for all the samples and the HPLC results 
are compared for all the samples. All the CE and HPLC results are listed in form 
of comparison charts.  
 
A comparison of results for all the amoxicillin samples analysed is given in the 
Figures 5.3.5, 5.3.7 (for samples containing 500 mg amoxicillin per capsule) and 




comparison of CE results for different brands of amoxicillin claimed to contain     
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Figure.5.3.5: comparison of CE results obtained for different brands of 
amoxicillin samples (claimed to contain 500 mg amoxicillin per capsule). The 
chart suggests that almost all the samples contain excess amount of amoxicillin 
compared to the claimed amount of 500 mg amoxicillin per sample capsule. 
 
Similarly the CE results for the samples claimed to contain 250 mg amoxicillin 
per sample capsule were compared separately and the comparison chart is given 
in the Figure 5.3.6 on the next page. 
518.5
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Comparison of CE for different brands of amoxicillin claimed to contain 
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Figure.5.3.6: The chart suggests that the sample HMC shows the same average 
amount of amoxicillin per sample capsule as the claimed amount of 250 mg 
amoxicillin per sample capsule using CE method. similarly sample Acamoxil is 
found to contain the same average amount of amoxicillin per sample capsule as 
the claimed amount of 250 mg amoxicillin per sample capsule. 
 
The HPLC results for all the samples were also compared and the values were 
expressed in the form of bar charts given in the Figure 5.3.7 and Figure 5.2.8 on 
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Figur.5.3.7: Comparison graph showing the HPLC results for different brands of 
amoxicillin. The results suggest that almost all the different brands of amoxicillin 
are found to contain the average amount of amoxicillin per sample capsule in 
excess to the claimed amount of 500 mg amoxicillin per sample capsule. 
 
The comparison of HPLC results for samples claimed to contain 250 mg 
amoxicillin per sample capsule is given in the form of a separate chart and is 
given in the Figure 5.3.8 on the following page. 
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Comparison of HPLC for different brands of amoxicillin claimed to contain 
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Figure.5.3.8: The chart suggests that the sample HMC shows a slightly higher 
average amount of amoxicillin per sample capsule compared to the claimed 
amount of 250 mg using HPLC method. While sample Acamoxil is found to 
contain nearly the same average amount of amoxicillin per sample capsule as 
the claimed amount of 250 mg amoxicillin per sample capsule. 
 
All the comparison charts given above explain the quality of all the different 
brands of amoxicillin samples obtained from different parts of the Middle East 
and Subcontinent. It was found that almost all the samples contained relative 
amount of active ingredients (amoxicillin) and did not show any counterfeiting 
excluding sample 10. 
 
Sample 10 (Acamoxil) was found to be counterfeiting as one capsule out of 4 did 
not contain any amoxicillin at all. There fore sample 10 (Acamoxil) was found to 
be counterfeit. All other samples contained excess amount of amoxicillin. 
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5.2: Comparison of IR Results Produced by all the Amoxicillin 
Samples to those Produced by Pure Amoxicillin. 
The characteristic strong peaks observed in the IR spectrum of all the amoxicillin 
samples are compared with IR spectrum of pure amoxicillin and are listed as 
follows. 
 
Table.5.1.4: Comparison of IR spectrum of all the amoxicillin samples with that of 
pure amoxicillin. 
 
Sample name  Absorb.(max)−1  Absorb.(max) −2 
Pure Amoxicillin 1686.32 cm-1 1775.10 cm-1 
Maxil  1686.34 cm-1 1775.21 cm-1 
Werrimox  1686.27 cm-1 1775.13 cm-1 
Amoxicillin  1686.43 cm-1 1774.97 cm-1 
Effimox 500 mg 1686.43 cm-1  1775.15 cm-1 
Namoxil  1686.27 cm-1 1775.13 cm-1 
Amoxascot  1686.29 cm-1 1775.15 cm-1 
Medimox 1686.27 cm-1 1775.13 cm-1 
Labmox  1686.27 cm-1 1775.13 cm-1 
HMC  1686.43 cm-1 1774.84 cm-1 
Acamoxil   1686.63 cm-1 1775.06 cm-1 
Glomox  1686.27 cm-1 1775.13 cm-1 
 
Similarly, all other peaks found in the IR spectra of different samples of 
amoxicillin were compared with IR spectrum of pure amoxicillin. It was found that 
all the IR spectra obtained for different samples of amoxicillin not only resemble 
the IR spectrum of pure amoxicillin were found similar for all of the amoxicillin 
samples. 
 
The similarity of all the peaks found in IR spectra of amoxicillin samples and pure 
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amoxicillin confirmed the presence of amoxicillin in all of the samples analysed 
using IR technique. After the presence of amoxicillin was confirmed in the 
samples, these samples were further analysed using HPLC and Capillary 
Electrophoresis. 
5.3: Critical Review of the Project Outcome: 
Reviewing all the results obtained for all the samples, it is found that all the 
samples (excluding sample 10) did not show any counterfeiting. However, the 
samples were found to have variation in the content uniformity within the same 
brand but still all these samples meet the international standards of quality 
control. 
 
Medicines can cause adverse effects if they are taken in excess to the amount 
prescribed by the physician or pharmacist. The patients are more likely to take 
excessive doses of the medicines having active ingredients in excess to the 
amount stated or mentioned by the manufacturer because the doctor or 
physician may prescribe the required quantity only according to the quantity 
mentioned by the manufacturer.  
 
Similarly, if a medicine is a combination of two active ingredients of which one is 
mentioned on the label or packaging of the medicine and the other is hidden. A 
patient is advised to take the said medicine according to the stated ingredient. 
The patient can be allergic to the ingredient not mentioned by the manufacturer 
and thus might experience an adverse effect. Such potentially dangerous drugs 
can be called as unexpected pharmaceuticals (Newton. P.N, et al: 2006 Lancet).  
 
A literature review shows that anti-infective drugs having little or no active 
ingredients may result in ineffective and even harmful treatment and can cause 
death in some cases (Newton. P.N, et al: 2006 Lancet).  
 
Anti-infective drugs having little or no active ingredients resulting in ineffective 
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treatment can increase the chances of spreading the infection or disease under 
treatment and eventually can lead to death. Therefore, any drug having little 
active ingredients or having active ingredients in excess to the amount claimed or 
stated by the manufacturer are as harmful and fatal as any other fake drug. 
 
As some of the amoxicillin samples analysed during this research project were 
found to contain higher values of amoxicillin compared to the amount stated by 
their respective manufacturers, but literature study reveals that all the samples 
meet the international quality standards of medicines i.e. a sample tablet or 
capsule of 500 mg should not contain less than 90 % of active ingredients of the 
stated amount and similarly no sample should contain more than 120 % of the 
stated amount (United State’s Pharmacopoeia).  
Summary of Chapter 5: 
The 1st section of chapter 5 comprises all the results and discussion of CE and 
HPLC and IR analysis of all amoxicillin samples. The average values of 
calculated amount of amoxicillin in all the samples were compared with the 
claimed amount of amoxicillin per sample capsule. The HPLC results were 
compared with CE results for all the samples. The comparison show that the 
results obtained from both HPLC and CE were almost the same with some minor 
differences for some of the samples. 
 
HPLC and CE results proved all the samples contained amoxicillin more or less 
the amount mentioned or stated by their manufacturers. All the samples were 
found to show a variation in content uniformity but did not show any 
counterfeiting excluding sample 10. The only sample was sample 10 which was 
found to be substandard or counterfeiting. One capsule out of four from sample 
10 did not contain any amoxicillin at all and was claimed by the manufacturer to 
contain 500 mg of amoxicillin per sample capsule. 
 
The IR results were discussed for all amoxicillin samples. The IR spectra of all 
 121 
the samples were compared to IR spectrum of pure amoxicillin. The IR results for 
all amoxicillin samples were the same as for pure amoxicillin confirming the 









































Chapter 6:  “conclusion and future study” 
 
This research project is aimed to study amoxicillin in counterfeit antibiotics from 
the Middle East and Subcontinent. These antibiotics were of different brands and 
were obtained from different parts of the Middle East and Subcontinent such as 
Iraq, China, India and Pakistan. The samples collected randomly from open 
market manufactured different companies of these different regions were anlysed 
quantitatively using the modern analytical techniques such as High Performance 
Liquid Chromatography and Capillary Electrophoresis and the results thus 
obtained were then compared for quality purpose to find counterfeiting. The 
project was started with the development of a suitable CE method for the 
analysis of amoxicillin and then further research work proceeded with the use of 
HPLC and IR.     
Conclusion: 
The literature review and extensive study on counterfeit drugs provided useful 
informations on counterfeiting around the world. The valuable research work 
previously done on counterfeiting by many research workers greatly highlights 
and explains the threat of counterfeiting in its all types and affirms that 
counterfeiting has become a major issue in poor and developing countries. 
 
The research work undertaken in this project was aimed on the analysis of 
amoxicillin containing antibiotics obtained from the open market of Middle East 
and Subcontinent. All the samples were randomly obtained without any 
discrimination or specification. The results produced by different brands of 
amoxicillin confirmed that out of 11 different amoxicillin samples, 10 samples did 
not show any counterfeiting and contained amoxicillin more or less the amount 
claimed by the manufacturers which meet the international standards of quality 
control. 
 
Eleven samples of amoxicillin from different countries of the Middle East and 
subcontinent were quantitatively analysed. It was found that all the samples 
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shown repeatability that is when an individual sample capsule from a particular 
brand was analysed several times, the results obtained after every single 
analysis were the same. At the same time it was found that the different capsules 
analysed from a particular brand did not contain the same amount of amoxicillin 
and a variation in content uniformity was found in all the samples.  The average 
values of HPLC and CE results for all the different samples are summarised and 
listed in the Table 6. 
 









stated Average STDEV + 
  (mg) (mg) (mg) (mg)   
Maxil 530.57 529.69 500 530.13 0.11 
Werrimox 517.42 518.57 500 517.99 0.57 
Amoxicillin 519.16 520.76 500 519.96 0.8 
Effimox 515.82 520.12 500 517.97 2.15 
Namoxil 521.3 520.48 500 520.89 0.41 
Amoxascot 524.49 524.49 500 524.49 0 
Medimox 506.4 506.4 500 506.4 0 
Labmox 507.73 506.28 500 507.0 0.72 
Glomox 516.82 521.64 500 519.23 2.41 
HMC 257.73 253.38 250 255.56 2.17 
Acamoxil 185.71 185.29 250 185.5 0.21 
 
All the results listed in the Table 6 were obtained from the experimental work 
undertaken during this project lead to a conclusion that all the different brands of 
amoxicillin (excluding sample 10: Acamoxil obtained from Iraq) contained 
amoxicillin more or less equal to the value claimed by their manufacturer and 
meet the international standards of quality control thus did not show any 
counterfeiting.  
 
Table 6 also shows that there is a difference in the HPLC and CE results. The 
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reason for this difference has not been investigated at this level of study. 
Furthermore, this difference appears not to be because of either HPLC or CE as 
the retention and migration time of amoxicillin samples recorded from HPLC 
analysis and CE analysis respectively is within the limits as found in the literature 
proving the instruments were accurate.  
 
Furthermore, sample 10 which was obtained from Iraq, was found to be 
counterfeit as one sample capsule (capsule 10 a) did not contain any amoxicillin 
at all. These results were confirmed after a repeated analysis of sample 10 a by 
HPLC and CE techniques. None of these two techniques confirmed the presence 
of any amoxicillin in the sample capsule 10 a. 
 
As other three capsules analysed from sample 10 produced good results and the 
quality standards were found to be within the limits of international standards of 
quality control. Hence, it is concluded that the manufacturer might have produced 
this drug having the quality standards which meet the international standards of 
quality control and that the counterfeiting might have come from any point along 
the distribution chain.  
 
One of the possibilities for this counterfeiting is that one of the original capsules 
might have been replaced with a capsule having no amoxicillin and the original 
product might have been repacked. As only four capsules out of ten from sample 
10 were analysed and one capsule was found counterfeit, there is the possibility 
of more counterfeit capsules in that pack of 10 capsules of sample 10 .i.e. more 
than one of the original capsules might have been replaced with the empty or 
inert ones.  
Future study: 
This project enabled the analysis of antibiotics using capillary electrophoresis and 
High Performance Liquid Chromatography under different experimental conditions 
helping the development of a suitable method on CE and HPLC for further project 
work. Further research work may help developing more easy and simple methods 
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of HPLC and CE analysis in the future to study not only counterfeit antibiotics but 
other counterfeit drugs as well.  
 
Further analysis could be carried out by keeping the antibiotic stock solution for 
several days and then analyse them on HPLC and CE. This will enable to find 
the difference between the results obtained from old stock solutions and those 
obtained from freshly prepared solutions. 
 
This project not only enables for further analysis of other antibiotics from Middle 
East and different countries from Asia such as Iran, Turkey, Nepal, Bangladesh, 
Afghanistan, Bhutan and Sri Lanka but will also facilitate the analysis of other 
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